Leafly (LFLY) 10-Q 13 Nov 23 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2023	Nov. 08, 2023
Entity Listings [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	001-39119
Entity Registrant Name	Leafly Holdings, Inc. /DE
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	84-2266022
Entity Address, Address Line One	113 Cherry Street, PMB 88154
Entity Address, City or Town	Seattle
Entity Address, State or Province	WA
Entity Address, Postal Zip Code	98104-2205
City Area Code	206
Local Phone Number	455-9504
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		2,177,721
Entity Central Index Key	0001785592
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false
Common Stock, $0.0001 Par Value
Entity Listings [Line Items]
Title of 12(b) Security	Common Stock, $0.0001 Par Value
Trading Symbol	LFLY
Security Exchange Name	NASDAQ
Warrants, exercisable for shares of common stock at an exercise price of $11.50 per share
Entity Listings [Line Items]
Title of 12(b) Security	Warrants, exercisable for shares of common stockat an exercise price of $11.50 per share
Trading Symbol	LFLYW
Security Exchange Name	NASDAQ

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 14,469	$ 24,594
Accounts receivable, net of allowance for doubtful accounts of $1,400 and $908, respectively	3,409	3,298
Prepaid expenses and other current assets	2,339	1,792
Restricted cash	0	360
Total current assets	20,217	30,044
Property, equipment, and software, net	2,541	2,285
Restricted cash - long-term portion	249	248
Other assets	55	135
Total assets	23,062	32,712
Current liabilities
Accounts payable	1,609	1,625
Accrued expenses and other current liabilities	2,990	6,235
Deferred revenue	2,095	1,958
Total current liabilities	6,694	9,818
Non-current liabilities
Non-current portion of convertible promissory notes, net	29,272	28,863
Total non-current liabilities	29,415	29,301
Total liabilities	36,109	39,119
Commitments and contingencies (Note 8)
Stockholders' deficit
Preferred stock: $0.0001 par value; 5,000 and 5,000 authorized; 0 and 0 issued and outstanding; aggregate liquidation preference of $0 and $0 at September 30, 2023 and December 31, 2022, respectively	0	0
Common stock: $0.0001 par value; 200,000 and 200,000 authorized; 2.311 and 2,164 issued at September 30, 2023 and December 31, 2022, respectively	0	0
Treasury stock: 154 and 154 shares held at September 30, 2023 and December 31, 2022, respectively	(31,663)	(31,663)
Additional paid-in capital	92,359	89,956
Accumulated deficit	(73,743)	(64,700)
Total stockholders' deficit	(13,047)	(6,407)
Total liabilities and stockholders' deficit	23,062	32,712
Private warrants derivative liability
Non-current liabilities
Derivative liability	113	182
Escrow shares derivative liability
Non-current liabilities
Derivative liability	5	52
Stockholder earn-out rights derivative liability
Non-current liabilities
Derivative liability	$ 25	$ 204

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 1,400	$ 908
Preferred stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Preferred stock, authorized (in shares)	5,000,000	5,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Preferred stock, aggregate liquidation preference	$ 0	$ 0
Common stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	200,000,000	200,000,000
Common stock, issued (in shares)	2,311,000	2,164,000
Treasury stock (in shares)	154,000	154,000

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Revenue	$ 10,583	$ 11,781	$ 32,507	$ 35,251
Cost of revenue	1,163	1,515	3,747	4,411
Gross profit	9,420	10,266	28,760	30,840
Operating expenses
Sales and marketing	2,563	6,403	10,326	21,529
Product development	2,533	3,406	8,133	10,927
General and administrative	5,799	6,489	17,475	20,730
Total operating expenses	10,895	16,298	35,934	53,186
Loss from operations	(1,475)	(6,032)	(7,174)	(22,346)
Interest expense, net	(720)	(705)	(2,157)	(2,119)
Change in fair value of derivatives	14	22,264	295	36,264
Other income (expense), net	(29)	(73)	(7)	(962)
Net (loss) income	$ (2,210)	$ 15,454	$ (9,043)	$ 10,837
Net (loss) income per share:
Basic (in usd per share)	$ (1.1)	$ 8.69	$ (4.58)	$ 6.15
Diluted (in usd per share)	$ (1.1)	$ 5.64	$ (4.58)	$ 5.45
Weighted average shares outstanding:
Basic (in shares)	2,011	1,779	1,974	1,763
Diluted (in shares)	2,011	2,149	1,974	1,924

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($) shares in Thousands, $ in Thousands	Total	2021 Notes	Preferred Stock	Common Stock	Common Stock 2021 Notes	Treasury Stock	Additional Paid-In Capital	Additional Paid-In Capital 2021 Notes	Accumulated Deficit
Balance at the beginning (in shares) at Dec. 31, 2021			307	1,254		0
Balance at the beginning at Dec. 31, 2021	$ (8,572)		$ 1	$ 0		$ 0	$ 61,197		$ (69,770)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(19,376)								(19,376)
Stock-based compensation	1,924						1,924
Exercise of stock options (in shares)				6
Exercise of stock options	127						127
Conversion of stock (in shares)			(307)	307	207
Conversion of stock		$ 33,024	$ (1)	$ 0			1	$ 33,024
Merger and recapitalization, net of fees (in shares)				100
Merger and recapitalization, net of fees	27,997						27,997
Stockholder contribution for debt issuance costs	924						924
Escrow shares derivative liability (in shares)				81
Escrow shares derivative liability	(6,867)						(6,867)
Private warrants derivative liability	(3,916)						(3,916)
Forward share purchase agreement derivative liability (in shares)				193
Forward share purchase agreement derivative liability	(14,170)						(14,170)
Stockholder earnout rights derivative liability	(26,131)						(26,131)
Balance at the end (in shares) at Mar. 31, 2022			0	2,148		0
Balance at the end at Mar. 31, 2022	(15,036)		$ 0	$ 0		$ 0	74,110		(89,146)
Balance at the beginning (in shares) at Dec. 31, 2021			307	1,254		0
Balance at the beginning at Dec. 31, 2021	(8,572)		$ 1	$ 0		$ 0	61,197		(69,770)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	10,837
Balance at the end (in shares) at Sep. 30, 2022				2,152		(154)
Balance at the end at Sep. 30, 2022	(1,398)			$ 0		$ (31,663)	89,198		(58,933)
Balance at the beginning (in shares) at Mar. 31, 2022			0	2,148		0
Balance at the beginning at Mar. 31, 2022	(15,036)		$ 0	$ 0		$ 0	74,110		(89,146)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	14,759								14,759
Stock-based compensation	464						464
Exercise of stock options (in shares)				1
Exercise of stock options	30						30
Balance at the end (in shares) at Jun. 30, 2022				2,149		0
Balance at the end at Jun. 30, 2022	217			$ 0		$ 0	74,604		(74,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	15,454								15,454
Shares canceled				(1)
Stock-based compensation	771						771
Exercise of stock options	1						1
Settlement of forward share purchase agreement derivative liability	(17,841)						(17,841)
Purchase of treasury stock (in shares)						(154)
Purchase of treasury stock						$ 31,663	(31,663)
Issuance of Common Stock upon vesting of restricted stock units (in shares)				4
Balance at the end (in shares) at Sep. 30, 2022				2,152		(154)
Balance at the end at Sep. 30, 2022	(1,398)			$ 0		$ (31,663)	89,198		(58,933)
Balance at the beginning (in shares) at Dec. 31, 2022			0	2,164		(154)
Balance at the beginning at Dec. 31, 2022	(6,407)		$ 0	$ 0		$ (31,663)	89,956		(64,700)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(5,397)								(5,397)
Stock-based compensation	658						658
Issuance of Common Stock under ESPP (in shares)				14
Issuance of Common Stock under ESPP	120						120
Issuance of Common Stock upon vesting of restricted stock units (in shares)				14
Balance at the end (in shares) at Mar. 31, 2023			0	2,192		(154)
Balance at the end at Mar. 31, 2023	(11,026)		$ 0	$ 0		$ (31,663)	90,734		(70,097)
Balance at the beginning (in shares) at Dec. 31, 2022			0	2,164		(154)
Balance at the beginning at Dec. 31, 2022	(6,407)		$ 0	$ 0		$ (31,663)	89,956		(64,700)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(9,043)
Balance at the end (in shares) at Sep. 30, 2023				2,311		(154)
Balance at the end at Sep. 30, 2023	(13,047)					$ (31,663)	92,359		(73,743)
Balance at the beginning (in shares) at Mar. 31, 2023			0	2,192		(154)
Balance at the beginning at Mar. 31, 2023	(11,026)		$ 0	$ 0		$ (31,663)	90,734		(70,097)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(1,436)								(1,436)
Stock-based compensation	580						580
Issuance of Common Stock upon vesting of restricted stock units (in shares)				31
Balance at the end (in shares) at Jun. 30, 2023				2,223		(154)
Balance at the end at Jun. 30, 2023	(11,882)			$ 0		$ (31,663)	91,314		(71,533)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(2,210)								(2,210)
Stock-based compensation	997						997
Reverse stock split , Shares				34
Reverse stock split				$ 0			0
Issuance of Common Stock under ESPP (in shares)				6
Issuance of Common Stock under ESPP	48						48
Issuance of Common Stock upon vesting of restricted stock units (in shares)				48
Balance at the end (in shares) at Sep. 30, 2023				2,311		(154)
Balance at the end at Sep. 30, 2023	$ (13,047)					$ (31,663)	$ 92,359		$ (73,743)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities
Net (loss) income	$ (9,043)	$ 10,837
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	697	276
Stock-based compensation expense	2,235	3,159
Bad debt expense, net of recoveries	2,350	1,023
Loss on disposition of assets	63	0
Noncash amortization of debt discount	409	369
Noncash interest expense associated with convertible debt	0	243
Noncash change in fair value of derivatives	(295)	(36,264)
Other	(1)	15
Changes in operating assets and liabilities:
Accounts receivable	(2,461)	(675)
Prepaid expenses and other current assets	(467)	(2,222)
Accounts payable	(16)	173
Accrued expenses and other current liabilities	(3,246)	(2,141)
Deferred revenue	137	77
Net cash used in operating activities	(9,638)	(25,130)
Cash flows from investing activities
Additions of property, equipment, and software	(1,042)	(2,194)
Proceeds from sale of property and equipment	27	0
Net cash used in investing activities	(1,015)	(2,194)
Cash flows from financing activities
Proceeds from exercise of stock options	0	158
Proceeds from convertible promissory notes	0	29,374
Proceeds from business combination placed in escrow and restricted	0	39,032
Trust proceeds received from recapitalization at closing	0	582
Issuance of common Stock under ESPP	168	0
Repurchase of common stock and settlement of forward purchase agreements	0	(31,303)
Transaction costs associated with recapitalization	0	(10,761)
Advances (repayments) of related party payables	1	(17)
Net cash provided by financing activities	169	27,065
Net decrease in cash, cash equivalents, and restricted cash	(10,484)	(259)
Cash, cash equivalents, and restricted cash, beginning of period	25,202	28,695
Cash, cash equivalents, and restricted cash, end of period	14,718	28,436
Supplemental disclosure of non-cash financing activities
Stockholder contribution for debt issuance costs	0	924
Repurchase of common stock in other accrued expenses	0	360
Conversion of promissory notes into common stock	0	33,024
Issuance of forward share purchase agreements	0	14,170
Issuance of private warrants	0	3,916
Issuance of sponsor shares subject to earn-out conditions	0	6,867
Issuance of stockholder earn-out rights	$ 0	$ 26,131

Description of the Business and

Description of the Business and Merger	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of the Business and Merger	NOTE 1 — Description of the Business and Merger Description of the Business Leafly Holdings, Inc. (“Leafly” or “the Company”) is an online cannabis discovery marketplace and resource for cannabis consumers. Leafly provides an information resource platform with a deep library of content, including detailed information about cannabis strains, retailers and current events. Leafly was incorporated in the state of Delaware on June 20, 2019 and is headquartered in Seattle, Washington. The Company has three wholly-owned subsidiaries, Leafly Canada Ltd., Leafly Deutschland GmbH and Leafly, LLC (“Legacy Leafly”). Legacy Leafly is the accounting predecessor of Leafly. The accompanying consolidated financial statements include the financial results of the Company and its wholly-owned subsidiaries. Merger with Merida On February 4, 2022, Leafly consummated the previously announced mergers and related transactions (collectively, the “Merger”) pursuant to the Agreement and Plan of Merger dated August 9, 2021 and amended on September 8, 2021 and on January 11, 2022 (as amended, the “Merger Agreement”). Legacy Leafly (formerly known as Leafly Holdings, Inc.) entered into the Merger Agreement with Merida Merger Corp. I (“Merida”), Merida Merger Sub, Inc., a Washington corporation (“Merger Sub I”) and Merida Merger Sub II, LLC, a Washington limited liability company (“Merger Sub II” and, together with Merger Sub I, the “Merger Subs”). Merger Sub I merged with and into Legacy Leafly, with Legacy Leafly surviving as a wholly-owned subsidiary of Merida, and following the initial Merger and as part of a single integrated transaction with the initial Merger, Legacy Leafly merged with and into Merger Sub II, with Merger Sub II surviving as a wholly-owned subsidiary of Merida. As a result of these Mergers, Legacy Leafly became a wholly owned subsidiary of Merida and was renamed Leafly, LLC, Merida was renamed Leafly Holdings, Inc. (“New Leafly”), and the securityholders of Legacy Leafly became security holders of New Leafly. We sometimes refer to the Mergers described above and the other transactions contemplated by the Merger Agreement and the other agreements being entered into by Merida and Legacy Leafly in connection with the Mergers as the “Business Combination” and to Merida following the Business Combination as “New Leafly.” While the legal acquirer in the Business Combination is Merida, for financial accounting and reporting purposes under accounting principles generally accepted in the United States of America (“GAAP”), Legacy Leafly is the accounting acquirer with the Merger accounted for as a “reverse recapitalization.” A reverse recapitalization does not result in a new basis of accounting, and the financial statements of the combined entity represent the continuation of the financial statements of Legacy Leafly. Under this accounting method, Merida is treated as the “ acquired ” company and Legacy Leafly is the accounting acquirer, with the transaction treated as a recapitalization of Legacy Leafly. Merida’s assets, liabilities and results of operations were consolidated with Legacy Leafly’s beginning on the date of the Business Combination. Except for certain derivative liabilities, the assets and liabilities of Merida were recognized at historical cost (which is consistent with carrying value) and were not material, with no goodwill or other intangible assets recorded. The derivative liabilities, which are discussed in Notes 13 and 18 , were recorded at fair value. The consolidated assets, liabilities, and results of operations of Legacy Leafly became the historical financial statements, and operations prior to the closing of the Business Combination presented for comparative purposes are those of Legacy Leafly. Pre-Merger shares of common stock and preferred stock were converted to shares of common stock of the combined company using the conversion ratio of 0.0164 and for comparative purposes, the shares and net loss per share of Legacy Leafly, prior to the Merger, have been retroactively restated using the conversion ratio.

Basis of Presentation and Signi

Basis of Presentation and Significant Accounting Policies	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation and Significant Accounting Policies	NOTE 2 — Basis of Present ation and Significant Accounting Policies Basis of Presentation The interim condensed consolidated financial statements have been prepared in accordance with GAAP and the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting and should be read in conjunction with the Company's audited consolidated financial statements for the years ended December 31, 2022 and 2021, and Management’s Discussion and Analysis of Financial Condition and Results of Operations of Leafly for the year ended December 31, 2022, each of which was filed with the SEC on March 29, 2023 (the “2022 Financial Information”). These condensed consolidated financial statements are unaudited and, in management's opinion, include all adjustments, consisting of normal recurring estimates and accruals necessary for a fair presentation of our consolidated cash flows, operating results, and balance sheets for the periods presented. Actual results may differ from these estimates and assumptions. The results of operations for any interim periods are not necessarily indicative of the results that may be expected for the entire fiscal year or any other interim period. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with GAAP have been omitted in accordance with the rules and regulations o f the SEC for interim reporting. All intercompany balances and transactions have been eliminated upon consolidation. Going Concern Evaluation Under the rules of ASC Subtopic 205-40 “Presentation of Financial Statements-Going Concern” (“ASC 205-40”), reporting companies are required to evaluate whether conditions and/or events raise substantial doubt about their ability to meet their future financial obligations as they become due within one year after the date that the financial statements are issued. This evaluation takes into account a company’s current available cash and projected cash needs over the one-year evaluation period but may not consider things beyond its control. Leafly has experienced revenue declines, incurred recurring operating losses, used cash from operations, and relied on the capital raised in the Business Combination to continue ongoing operations. These conditions, when considered in the aggregate, raise substantial doubt about Leafly’s ability to continue as a going concern within one year of the date these financial statements are issued. In response to these conditions, Leafly management took the following actions: • During the fourth quarter of 2022, Leafly implemented a restructuring plan, including a reduction in force reflecting primarily one-time severance and other employee-related termination benefits incurred during the fourth quarter of 2022. • During the three months ended March 31, 2023, Leafly announced a second restructuring plan further seeking to reduce recurring costs and operating expenditures and identifying cost savings based on a reduction in force reflecting primarily one-time severance and other employee-related termination benefits incurred during the first quarter of 2023. The restructuring plans above have been implemented and are expected to continue contributing to the cash savings of the Company. The Company’s management is closely monitoring and reducing operating expenses where it is able to, while ensuring the trajectory and viability of the business remains intact. After considering all available evidence, Leafly’s management determined that, based on the cost reduction measures outlined in both actions above, Leafly’s current positive working capital will be sufficient to meet its capital requirements for a period of at least 12 months from the date that these September 30, 2023 financial statements are issued. Reverse Stock Split On September 12, 2023, the Company implemented a one-for-twenty reverse split of its common stock ( Note 12 ). To facilitate comparative analysis, all statements in this Quarterly Report regarding numbers of shares of common stock and all references to prices of a share of common stock, if referencing events or circumstances occurring prior to September 12, 2023, have been retroactively restated to reflect the effect of the reverse stock split on a pro forma basis. Reclassifications Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no effect on the reported net (loss) income. Seasonality We may experience seasonality in our business, which we believe has moderate impacts on our overall revenue. In certain years, we've seen seasonal fluctuations that coincide with either federal holidays, generally in the fourth quarter, or industry holidays and events, generally in the spring. Our industry and business history is limited and therefore we cannot be certain that these are known trends or that other trends may develop. Emerging Growth Company Status Leafly is an emerging growth company (“EGC”), as defined in the Jumpstart Our Business Startups Act (“JOBS Act”). Under the JOBS Act, EGCs can delay adopting new or revised accounting standards issued until such time as those standards apply to private companies. The Company has elected to use this extended transition period. In providing this relief, the JOBS Act does not preclude the Company from adopting a new or revised accounting standard earlier than the time that such standard applies to private companies. Leafly will continue to use this relief until the earlier of the date that it (a) is no longer an EGC or (b) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses in the condensed consolidated financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates. Such estimates include those related to the fair value of derivative liabilities; the allowance for doubtful accounts; the valuation allowance for deferred income tax assets; the fair value of the convertible promissory notes; the estimate of capitalized software costs and useful life of capitalized software; and the fair value of equity issuances. Management bases its estimates on historical experience, knowledge of current events and actions it may undertake in the future that management believes to be reasonable under the circumstances. Actual results may differ from these estimates and assumptions. Significant Accounting Policies The unaudited interim financial statements should be read in conjunction with the Company's 2022 Financial Information, which describes the Company's significant accounting policies. There have been no material changes to the Company's significant accounting policies during the nine months ended September 30, 2023 compared to our 2022 Annual Report. Recent Accounting Pronouncements Accounting Pronouncements Issued But Not Yet Adopted Management does not believe that there are any recently issued, but not yet effective, accounting standards that, if currently adopted, would have a material effect on the Company’s consolidated financial statements or related disclosures.

Cash, Cash Equivalents, and Res

Cash, Cash Equivalents, and Restricted Cash	9 Months Ended
	Sep. 30, 2023
Cash and Cash Equivalents [Abstract]
Cash, Cash Equivalents, and Restricted Cash	NOTE 3 — Cash, Cash Equival ents, and Restricted Cash Cash, cash equivalents, and restricted cash consisted of the following: September 30, 2023 December 31, 2022 Cash and cash equivalents $ 14,469 $ 24,594 Restricted cash — 360 Restricted cash - long-term portion 249 248 $ 14,718 $ 25,202 The restricted cash balance at December 31, 2022 included $ 360 of cash maintained in escrow related to Forward Share Purchase Agreemen ts (“FPAs”). Effe ctive August 1, 2022, the “FPA Holders” elected to have Leafly repurchase their remaining 154 shares covered by the FPAs for an aggregate repurchase price of $ 31,663 . As a result, the shares repurchased have been removed from Leafly's outstanding shares effective as of the date of purchase and placed into treasury. The FPA Holders elected to have all but $ 360 disbursed from the escrow account and were able to claim the remainder any time until August 1, 2 023. On July 11, 2023, Leafly returned $ 360 of restricted cash to the FPA Holders pursuant to the terms of the FPAs. Additional information regarding the FPAs is included in Notes 13 and 18 .

Prepaid Expenses and Other Asse

Prepaid Expenses and Other Assets	9 Months Ended
	Sep. 30, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid Expenses and Other Assets	NOTE 4 — Prepaid Expenses and Other Assets Prepaid expenses and other assets consist of the following: September 30, 2023 December 31, 2022 Prepaid subscriptions $ 703 $ 916 Prepaid insurance 1,277 533 Other prepaid assets 186 272 Other current assets 173 71 Subtotal, current portion 2,339 1,792 Prepaid expenses, long-term portion 55 135 Total $ 2,394 $ 1,927

Accounts Receivable, Net

Accounts Receivable, Net	9 Months Ended
	Sep. 30, 2023
Receivables [Abstract]
Accounts Receivable, Net	NOTE 5 — Account s Receivable, Net Accounts receivable, net of $ 3,409 and $ 3,298 as of September 30, 2023 and December 31, 2022, respectively, consisted of amounts due from customers less an allowance for doubtful accounts. For further information about revenue and deferred revenues, see Note 9 . The following table presents the allowance for doubtful accounts and the changes therein: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Balance, beginning of period $ 1,404 $ 1,469 $ 908 $ 1,848 Add: provision for doubtful accounts, net of recoveries 940 383 2,350 1,023 Less: write-offs ( 944 ) ( 894 ) ( 1,858 ) ( 1,913 ) Balance, end of period $ 1,400 $ 958 $ 1,400 $ 958

Property, Equipment and Softwar

Property, Equipment and Software, Net	9 Months Ended
	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Property, Equipment, and Software, Net	NOTE 6 — Property, Equi pment, and Software, Net Property, equipment, and software consisted of the following: September 30, 2023 December 31, 2022 Furniture and equipment $ 454 $ 740 Capitalized internal-use software 3,352 2,310 3,806 3,050 Less: accumulated depreciation and amortization ( 1,265 ) ( 765 ) $ 2,541 $ 2,285 The Company recognized depreciation and amortization expense as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Depreciation expense $ 21 $ 37 $ 68 $ 135 Amortization of capitalized internal-use software 255 90 629 141 Total depreciation and amortization $ 276 $ 127 $ 697 $ 276 During the nine months ended September 30, 2023 , the Company disposed of equipment with a book value of $ 90 for $ 27 , resulting in a loss on disposal of $ 63 . During the three months ended September 30, 2023 , the Company disposed of equipment with a book value of $ 88 for $ 16 , resulting in a loss on disposal of $ 72 .

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	9 Months Ended
	Sep. 30, 2023
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	NOTE 7 — Accrued Expenses and Other Current Liabilities Accrued expenses consisted of the following: September 30, 2023 December 31, 2022 Accrued bonuses $ 922 $ 1,309 Other employee-related liabilities 1,068 2,403 Accrued interest 400 1,000 Other accrued expenses 1 600 1,523 $ 2,990 $ 6,235 1. There are no individual items within this balance that exceed 10% of the total of the table .

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 8 — Commitme nts and Contingencies In the normal course of business, the Company may receive inquiries or become involved in legal disputes regarding various litigation matters. In the opinion of management, any potential liabilities resulting from such claims would not have a material adverse effect on the Company’s consolidated financial statements. Leases The Company does not have any leases with an original term longer than 12 months as of September 30, 2023. The Company has short-term arrangements with immaterial rental obligations for office space. Nasdaq Notifications of Noncompliance On October 28, 2022, the Company received a letter from the staff (the “Staff”) of Nasdaq providing notification that the Company no longer complied with the $ 50 million in market value of listed securities standard for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) and that the Company also did not comply with either of the two alternative standards of Listing Rule 5450(b), the equity standard and the total assets and total revenue standard. On April 19, 2023, Nasdaq approved the Company’s application to transfer the listing of its common stock and warrants from the Nasdaq Global Market to the Nasdaq Capital Market, effective April 21, 2023, on the basis that the Company complied with the net income standard for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(3). The transfer of the listing resolved the October 28, 2022 noncompliance notification. On November 2, 2022, the Company received a letter from the Staff of the Nasdaq indicating that it did not meet the requirement to maintain a minimum bid price of $ 1 per share, which is imposed by Nasdaq Listing Rule 5450(a)(1) for continued listing on the Nasdaq Global Market and by Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market (the “Bid Price Requirement”) and that it had until May 1, 2023 to regain compliance. On May 2, 2023, as a result of the Company not regaining compliance with the Bid Price Requirement, the Company received a letter from Nasdaq notifying it that the Company’s common stock would be subject to delisting from Nasdaq unless the Company timely requested a hearing before a Nasdaq Hearings Panel (the “Panel”) and submitted a plan of compliance. The Company submitted a plan, and on May 23, 2023, the Panel approved it, giving the Company until October 30, 2023 to regain compliance with the Bid Price Requirement. On September 12, 2023, the Company implemented a one-for-twenty reverse split of its common stock ( Note 12 ), and on September 29, 2023, the Company received formal notice from Nasdaq confirming that the Company regained compliance with the Bid Price Requirement, will continue to be listed and traded on the Nasdaq Capital Market and the listing matter was closed.

Revenue and Contract Balances

Revenue and Contract Balances	9 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue and Contract Balances	NOTE 9 — Revenue and Contract Balances The following table presents the Company's revenue by service type: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Advertising 1 $ 10,386 $ 11,731 $ 32,126 $ 34,914 Other services 1 197 50 381 337 $ 10,583 $ 11,781 $ 32,507 $ 35,251 1. Amounts for the prior period have been reclassified to conform to the current period presentation. The following table presents the Company's revenue by geographic region: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 United States 1 $ 10,155 $ 11,140 $ 31,213 $ 32,742 All other countries 1 428 641 1,294 2,509 $ 10,583 $ 11,781 $ 32,507 $ 35,251 1. Amounts for the prior period have been reclassified to conform to the current period presentation. The following table presents the Company's revenue by state: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Arizona 20 % 19 % 20 % 18 % California 12 % 13 % 12 % 11 % Oregon 11 % 10 % 11 % 10 % No other state comprised 10% or more of Leafly’s revenue during the nine months ended September 30, 2023 and 2022. We have a diversified set of customers; no single customer accounted for 10% or more of our revenue for the nine months ended September 30, 2023 or 2022. The following table presents the Company's revenue by timing of recognition: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Over Time 1 Retail 2 $ 9,266 $ 9,042 $ 27,576 $ 27,286 Brands 3 929 1,758 3,571 5,067 10,195 10,800 31,147 32,353 Point in time 1 Brands 4 388 981 1,360 2,898 $ 10,583 $ 11,781 $ 32,507 $ 35,251 1. Amounts for the prior period have been reclassified to conform to the current period presentation. 2. Revenues from subscription services and display ads. 3. Revenues from brand profile subscriptions and digital media (including display ads and audience extension). 4. Revenues from channel advertising (including direct to consumer email). Revenues recognized over time are associated with software subscriptions, display ads and audience extension. Revenues recognized at a point in time are associated with branded content and channel advertising. There are no material variations in delivery and revenue recognition periods within the over time category. Contract liabilities consist of deferred revenue, which is recorded on the Consolidated Balance Sheets when the Company has received consideration, or has the right to receive consideration, in advance of transferring the performance obligations under the contract to the customer. The following table presents the Company's deferred revenue balances and changes therein: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Balance, beginning of period $ 2,017 $ 2,467 $ 1,958 $ 1,975 Add: net increase in current period contract liabilities 1,991 1,630 2,083 1,976 Less: revenue recognized from beginning balance ( 1,913 ) ( 2,045 ) ( 1,946 ) ( 1,899 ) Balance, end of period $ 2,095 $ 2,052 $ 2,095 $ 2,052 A majority of the deferred revenue balance as of September 30, 2023 is expected to be recognized in the subsequent 12-month period. No other contract assets or liabilities are recorded on the Company’s Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022 .

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 10 — In come Taxes The Company’s effective tax rate was 0 % for the three and nine months ended September 30, 2023 and 2022. The effective tax rate was lower than the U.S. federal statutory rate of 21% due to the Company’s full valuation allowance recorded against its deferred tax assets. The Company had net operating loss carryforwards (“NOLs”) for federal, state and foreign income tax purposes of approximately $ 85,430 , $ 60,478 and $ 5,801 , respectively, as of December 31, 2022 . The Company's state NOL will begin to expire in 2039 , and all of the Company's federal NOLs will last indefinitely. The Internal Revenue Code of 1986, as amended (the “Code”), imposes restrictions on the utilization of NOLs in the event of an “ownership change” of a corporation. Accordingly, a company’s ability to use NOLs may be limited as prescribed under Code Section 382 (“IRC Section 382”). Events which may cause limitations in the amount of the NOLs that the Company may use in any one year include, but are not limited to, a cumulative ownership change of more than 50 % over a three-year period. Utilization of the federal and state NOLs may be subject to substantial annual limitation due to the ownership change limitations under IRC Section 382 and similar state provisions. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company files income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. Management believes all the income tax returns filed since inception remain open to examination by the major domestic and foreign taxing jurisdictions to which the Company is subject due to NOLs.

Convertible Promissory Notes

Convertible Promissory Notes	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Convertible Promissory Notes	NOTE 11 — C onvertible Promissory Notes 2022 Notes Merida entered into a $ 30,000 convertible note purchase agreement (the “Note Purchase Agreement”) in January 2022, which Legacy Leafly subsequently guaranteed and joined as a party to the agreement on February 4, 2022 in connection with the Business Combination (the “2022 Notes”). Accordingly, post-Business Combination, the 2022 Notes are presented as a liability on Leafly's balance sheet, net of debt issuance costs and debt discount. The Company recognized debt issuance costs of $ 714 paid in cash, and a debt discount of $ 924 paid in shares transferred by Merida Holdings, LLC (the “Sponsor”) to the holders of the 2022 Notes upon issuance. The 2022 Notes bear interest at 8 % annually, paid in cash semi-annually in arrears on July 31 and January 31 of each year, and mature on January 31, 2025. The 2022 Notes are unsecured convertible senior notes due 2025. They are convertible at the option of the holders at any time before maturity at an initial conversion share price of $ 250.00 per $ 1,000 principal amount of 2022 Notes and per $ 1,000 of accrued but unpaid interest on any converted 2022 Notes. In addition, the Company may, at its election, force the conversion of the 2022 Notes on or after January 31, 2024, if the volume-weighted average trading price of the Company’s common stock exceeds $ 360.00 for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days. The Company also has the option, on or after January 31, 2023 and prior to the 40th trading day immediately before the maturity date and subject to the holders’ ability to optionally convert, to redeem all or a portion of the 2022 Notes at a cash redemption price equal to 100 % of the principal amount of the 2022 Notes, plus accrued and unpaid interest, if any. The holders of the 2022 Notes have the right to cause the Company to repurchase for cash all or a portion of the 2022 Notes held by such holder upon the occurrence of a “fundamental change” (as defined in the Note Purchase Agreement) or in connection with certain asset sales, in each case at a price equal to 100 % of par plus accrued and unpaid interest, if any. As of September 30, 2023, the net carrying amount of the 2022 Notes was $ 29,272 , which includes unamortized issuance costs and debt discount of $ 728 , which will be amortized over the remaining term. The estimated fair value of the convertible debt instruments was approximately $ 27,000 as of September 30, 2023. The fair value of the 2022 Notes was measured using the Bloomberg OVCV model and CNVI model which modifies the underlying OVCV program. These models incorporate inputs for volatility, Leafly’s stock price, time to maturity, the risk-free rate and Leafly’s credit spread, some of which are considered Level 3 inputs in the fair value hierarchy. 2021 Notes Legacy Leafly issued a series of convertible promissory notes in June 2021 totaling approximately $ 23,970 . In August 2021, Legacy Leafly issued additional convertible promissory notes totaling $ 7,500 to Merida Capital, an affiliate of Merida. (Both note issuances are collectively referred to below as the “2021 Notes”). The 2021 Notes bore interest at 8 % annually and were considered traditional convertible debt with the entire amount recognized as a liability (with no amount allocated to equity), reduced for direct issuance costs, with initial and subsequent recognition at amortized cost in accordance with the interest method. Unless converted, the entire balance of principal and accrued but unpaid interest was due on December 3, 2022. The 2021 Notes were contingently convertible upon the occurrence of certain events, to include a qualified financing, a non-qualified financing, or in a qualified public transaction. On February 4, 2022, in connection with the Business Combinat ion, the 2021 Notes were converted to approximately 206 shares of Leafly common stock at the conversion price of approximately $ 52.60 , which was 80 % of the implied price per share of common stock in the Business Combination. Upon closing of the Business Combination, the shares of common stock then converted to shares of common stock of the combined company using the conversion ratio of 0.0164 , which was used for conversion of all Leafly securities.

Stockholders' Deficit

Stockholders' Deficit	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Stockholders' Deficit	NOTE 12 — Sto ckholders’ Deficit Common Stock Reverse Stock Split On July 12, 2023, during the Company’s 2023 Annual Meeting of Stockholders, Leafly’s stockholders approved a proposal for a reverse stock split (the “Reverse Stock Split”) as part of the Company’s plan to regain compliance with the Bid Price Requirement under Nasdaq listing rules ( Note 8 ). Effective September 12, 2023, the Company effected a one-for- twenty (1-for-20) Reverse Stock Split of its common stock. As a result of the Reverse Stock Split: • Every twenty (20) shares of common stock issued and outstanding were combined and converted into one (1) issued and outstanding share of common stock. o The Reverse Stock Split did not change the authorized number of shares or the par value of the common stock, nor modify any voting rights of the common stock, which continues to trade on the Nasdaq Capital Market under its existing symbol “LFLY” on a split-adjusted basis. o All shares of common stock that were held by a stockholder were aggregated and converted at the 1-for-20 reverse split ratio subsequent to the Reverse Stock Split, and each fractional share held by a stockholder resulting from such aggregation and conversion was rounded up to the next whole share. o Leafly issued 34 shares in connection with the above criteria. No fractional shares were issued in connection with the Reverse Stock Split. • The Company’s public warrants continue to trade on the Nasdaq Capital Market under the existing symbol “LFLYW.” o All outstanding warrants have been adjusted in accordance with their terms, resulting in the number of shares issuable upon exercise of a warrant holder’s aggregate number of warrants, after adjustment, being rounded up to the nearest whole share and proportionate adjustments were made to the exercise price; • All outstanding convertible notes have been adjusted such that the conversion rate and the conversion price have been made proportionate with the 1-for-20 reverse split ratio in accordance with their terms. • Based on the 1-for-20 reverse split ratio, the number of shares of common stock issuable under the Company’s outstanding equity awards decreased proportionately, with any fractional shares rounded down to the nearest whole share, with a corresponding adjustment made to the exercise prices of outstanding option awards, rounded up to the nearest whole cent. o In addition, the number of shares of common stock available for issuance under the Company’s equity incentive plans were proportionately adjusted based on the 1-for-20 reverse split ratio, such that fewer shares are available for issuance under our equity incentive plans. To facilitate comparative analysis, all statements in this Quarterly Report regarding numbers of shares of common stock and all references to prices of a share of common stock, if referencing events or circumstances occurring prior to September 12, 2023, have been retroactively restated to reflect the effect of the Reverse Stock Split on a pro forma basis. Business Combination The Consolidated Statements of Changes in Stockholders' Deficit reflect the reverse recapitalization on February 4, 2022, as discussed in Note 1 . Since Legacy Leafly was determined to be the accounting acquirer in the Business Combination, all periods presented prior to consummation of the Business Combination reflect the historical activity and balances of Legacy Leafly (other than common and preferred stock and potentially issuable shares underlying stock options and convertible promissory notes, which have been retroactively restated). On February 4, 2022, the Business Combination was consummated pursuant to the Merger Agreement. Prior to the Business Combination, Legacy Leafly's capital stock consisted of Series A preferred stock and common stock. Upon the consummation of the Business Combination, all issued and outstanding shares of Series A preferred stock converted to shares of nonredeemable common stock. In connection with the settlement of the FPAs ( Note 13 ), appr oximately 1 shares of the Company’s common stock held by the Sponsor were canceled, according to an agreement between the Company and the Sponsor entered into upon execution of the FPAs. As of September 30, 2023, Leafly's authorized capital stock consisted of: • 200,000 shares of Leafly common stock, $ 0.0001 par value per share; and • 5,000 shares of Leafly preferred stock, $ 0.0001 par value per share. Sponsor Shares Subject to Earn-Out Conditions In accordance with the Merger Agreement, upon closing of the Business Combination, 81 of the shares of the Company’s common stock held by the Sponsor were placed in escrow and subjected to earn-out conditions (“Escrow Shares”). Of these Escrow Shares, 50 % will be released from escrow if and when the Company's common stock trades at or above $ 270.00 for 20 out of 30 consecutive trading days at any time during the two-year period following closing of the Business Combination, and the remaining 50 % will be released from escrow if and when the Company's common stock trades at or above $ 310.00 for 20 out of 30 consecutive trading days at any time during the three-year period following closing of the Business Combination. In addition, all 81 Escrow Shares will be released upon a change in control. We account for the Escrow Shares as derivative liabilities, remeasured to fair value on a recurring basis, with changes in fair value recorded to earnings. See Note 18 for additional information. Treasury Stock Effective August 1, 2022, the Company repurchased 154 shares of its common stock at a weighted-average price of $ 205.60 per share for a total of $ 31,663 , with $ 31,303 paid with restricted cash held in escrow at the time and $ 360 remaining in accrued expenses and other current liabilities on our consolidated balance sheet at December 31, 2022. These repurchases were in settlement of the FPAs. See Notes 3 and 13 for additional information. Stockholder Earn-Out Rights Leafly stockholders, as of immediately prior to the closing of the Business Combination, were granted upon closing of the Business Combination, contingent rights to recei ve up to 271 shares of common stock (the “Rights”) if the Company achieves certain earn-out conditions prior to the third anniversary of the Business Combination. We will account for the Rights as derivative liabilities, which we will remeasure to their current fair value as of the end of each reporting period, with changes in the fair value recorded to earnings. See Note 18 for additional information. The Rights will be earned and shares of common stock will be issued as follows: First Tranche Up to 136 shares will be issued if and when: • revenue for the year ended December 31, 2022 equaled or exceeded $ 65,000 (“first revenue target”, which was not met), or • the date on which the volume-weighted average price of common stock for a period of at least 20 days out of 30 consecutive trading days ending on the trading day immediately prior to the date of determination is greater than or equal to $ 270.00 (“first target price”) during the two-year period beginning on the trading day after the closing date of the Merger (as adjusted for stock splits, reverse stock splits, stock dividends, reorganizations, recapitalizations, reclassifications, combinations, exchanges of shares or other like changes or transactions with respect to shares of common stock occurring at or after the closing of the Business Combination) (the “first target period”), or • a change of control occurs within the first target period at the first target price or higher, or • a pro rata por tion of 136 shares ( 50 %) if the revenue during the first target period meets or exceeds 90 % of the first revenue target. Second Tranche Up to 136 shares will be issued if and when: • revenue for the year ending December 31, 2023 equals or exceeds $ 101,000 (“second revenue target”), or • the date on which the volume-weighted average price of common stock for a period of at least 20 days out of 30 consecutive trading days ending on the trading day immediately prior to the date of determination is greater than or equal to $ 310.00 (“second target price”) during the three-year period beginning on the trading day after the closing date of the Business Combination (as adjusted for stock splits, reverse stock splits, stock dividends, reorganizations, recapitalizations, reclassifications, combinations, exchanges of shares or other like changes or transactions with respect to shares of common stock occurring at or after the closing of the Business Combination) (the “second target period”), or • a change of control occurs within the second target period at the second target price or higher, or • a pro rata portion of 136 ( 50 %) if the revenue during the second target period meets or exceeds 90 % of the second revenue target. If the second revenue target or second target price is met in full, the respective first revenue target or first target price, as applicable, will be deemed to have been met as well if it had not been met during the first target period. Preferred Stock The Board is authorized, subject to limitations prescribed by the law of the State of Delaware, to issue Leafly preferred stock from time to time in one or more series. The Board is authorized to establish the number of shares to be included in each such series and to fix the voting rights, if any, designations, powers, preferences and relative, participating, optional, special and other rights, if any, and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The Board is able, without stockholder approval, to issue Leafly preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of the Leafly common stock and could have anti-takeover effects. The ability of the Board to issue Leafly preferred stock without stockholder approval could have the effect of delaying, deferring or preventing a change of control of Leafly or the removal of existing management. Leafly did no t have any issued and outstanding shares of preferred stock as of September 30, 2023 or December 31, 2022 .

Warrants and Forward Purchase S

Warrants and Forward Purchase Share Agreements	9 Months Ended
	Sep. 30, 2023
Other Liabilities Disclosure [Abstract]
Warrants and Forward Purchase Share Agreements	NOTE 13 — Warran ts and Forward Share Purchase Agreements Public Warrants At each of September 30, 2023 and December 31, 2022 , there were 6,501 warrants outstanding to purchase an aggregate of 325 shares of common stock that had been included in the units issued in Merida’s initial public offering (the “Public Warrants”). Each Public Warrant entitles the holder to purchase 0.05 shares of common stock at an exercise price of $ 230.00 per whole share. Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants became exercisable 30 days after the closing of the Business Combination. The Public Warrants may not be exercisable for cash unless the Company has an effective and current registration statement covering the shares of common stock issuable upon exercise of the Public Warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, during any period when the Company shall have failed to maintain an effective registration statement, warrant holders may exercise their Public Warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their Public Warrants on a cashless basis. The Public Warrants will expire five years after the closing of the Business Combination or earlier upon redemption or liquidation. The Company may redeem the Public Warrants: • in whole and not in part; • at a price of $ 0.20 per warrant; • upon not less than 30 days’ prior written notice of redemption; • if, and only if, the reported last sale price of the Company’s common stock equals or exceeds $ 360.00 per share for any 20 trading days within a 30 -trading day period commencing after the warrants became exercisable and ending on the third business day prior to the notice of redemption to the warrant holders; and • if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. Private Warrants At each of September 30, 2023 and December 31, 2022 , there were 3,950 warrants outstanding to purchase an aggregate of 198 shares of common stock that Merida had sold to the Sponsor and EarlyBirdCapital in a private placement that took place simultan eously with Merida’s initial public offering (the “Private Warrants”). The Private Warrants are identical to the Public Warrants, except that the Private Warrants and the shares of common stock issuable upon the exercise of the Private Warrants were not transferable, assignable or salable until after the closing of the Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants are exercisable for cash or on a cashless basis, at the holder’s option, and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants are redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. The exercise price and number of shares of common stock issuable upon exercise of the Private Warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the Private Warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Private Warrants. We account for the Private Warrants as derivative liabilities, remeasured to fair value on a recurring basis, with changes in the fair value recorded to earnings. See Note 18 for additional information. Forward Share Purchase Agreements In December 2021 and Jan uary 2022, the Company entered into four separate FPAs with the FPA Holders. The FPAs allowed the FPA Holders to sell and transfer common stock held by such holders, not to exceed a total of 200 shares in aggregate, to the Company in exchange for cash. The price to be paid by the Company was initially $ 203.20 per share for up to 130 shares and $ 200.20 per share for up to 70 shares. As required by the FPAs, $ 39,032 of cash was placed into escrow upon closing of the Business Combination, to be used for the share purchases. If the FPAs were not exercised by the FPA Holders within their terms of three months post-Business Combination closing, the associated funds were to be released from escrow to the Company. We account for the FPAs as derivative liabilities, remeasured to fair value on a recurring basis, with changes in the fair value recorded to earnings. On May 3, 2022, Leafly and the FPA Holders entered into amendments to the FPAs (the “Amended FPAs”). The Amended FPAs modified the price at which the applicable FPA Holder has the right, but not the obligation, to have Leafly repurchase certain shares held by the applicable FPA Holder as of the closing of the Business Combination and not later sold into the market at a price of $ 203.20 per share (with respect to 34 of the shares subject to the Amended FPAs) and $ 206.20 per share (with respect to 120 of the shares subject to the Amended FPAs). The Amended FPAs also modified the date by which such FPA Holders could elect to have Leafly repurchase their shares to August 1, 2022. In connection with the Amended FPAs, certain amendments were also made to the escrow agreements in respect of the escrow accounts. During the year ended December 31, 2022, a total of $ 8,089 was released from the escrow accounts due to certain FPA Holders selling shares in the open market, which was accordingly reclassified on the Company's balance sheet from restricted cash to cash. Effective August 1, 2022, the FPA Holders elected to have Leafly repurchase their remaining 154 shares covered by the FPAs for an aggregate repurchase price of $ 31,663 . As a result, the shares repurchased have been removed from Leafly's outstanding shares effective as of the date of purchase, and placed into treasury. The FPA Holders elected to have all but $ 360 disbursed from the escrow account and were able to claim the remainder any time until August 1, 2023. On July 11, 2023, Leafly returned $ 360 of restricted cash to the FPA Holders pursuant to the terms of the FPAs ( Note 3 ). Also, in connection with the settlement, approximately 1 shares of the Company’s common stock held by the Sponsor were canceled, according to an agreement between the Company and the Sponsor entered into upon execution of the FPAs.

Equity Incentive and Other Plan

Equity Incentive and Other Plans	9 Months Ended
	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Equity Incentive and Other Plans	NOTE 14 — Equity Inc entive and Other Plans The Company currently has four equity plans: the New Leafly 2021 Equity Incentive Plan (the “2021 Plan”), the Legacy Leafly 2018 Equity Incentive Plan (the “2018 Plan”), the New Leafy Earn-Out Plan (the “Earn-Out Plan”), and the New Leafly 2021 Employee Stock Purchase Plan (the “ESPP”). Activity under the 2021 Plan and the ESPP are detailed below. There were no options or other equity awards granted under the 2018 Plan or the Earn-Out Plan during the nine months ended September 30, 2023. Stock-Based Compensation 2021 Plan The 2021 Plan became effective immediately upon closing of the Business Combination. Pursuant to the 2021 Plan, 225 shares of common stock were initially reserved for issuance. During the term of the 2021 Plan, the number of shares of common stock thereunder automatically increases on each January 1, commencing on January 1, 2023, and ending on (and including) January 1, 2031, by the lesser of (i) 10 % of the fully diluted shares of common stock as of the last day of the preceding fiscal year and (ii) 225 shares (adjusted pursuant to the terms of the 2021 Plan). Effective January 1, 2023, 221 shares of common stock were available for issuance under the 2021 Plan and 49 remained available at September 30, 2023. 2022 Awards In August 2022 and October 2022, the Company granted stock options to purchase an aggregate of approximately 5 shares of common stock at a weighted-average exercise price of $ 39.60 per share and granted an aggregate of 128 restricted stock units (“RSUs”) and performance stock units (”PSUs”). Of the PSUs granted, 34 were market-based awards made to executives with a grant date fair value of $ 0.80 per share with vesting based on achievement of a $ 1.0 billion market cap by February 4, 2026, and 7 were performance awards made to executives with a grant date fair value of $ 16.20 per share with vesting based in part on achievement of a fiscal year 2022 adjusted EBITDA target, as defined in the award agreements, which was achieved. Prior to such grants, no grants had been made under the 2021 Plan. On March 13, 2023, the Company approved the vesting of 7 PSUs awarded in 2022, which vested based on the achievement of the Company’s 2022 adjusted EBITDA target, on March 13, 2023. 2023 Awards The Company granted 32 annual incentive plan RSUs on March 14, 2023, which vested over four months . On July 25, 2023, the Company granted: 126 service-based RSUs to employees, which are scheduled to vest over a two-year period from the initial vest date; 33 RSUs to non-employee Board members, which vested in full on August 20, 2023 ; and 24 PSUs to senior management, with vesting contingent upon the Company meeting certain fiscal year 2023 financial performance metrics, as specified in the award agreements. Stock Options The fair value of each stock option award is estimated on the date of grant using the Black-Scholes option pricing model. No options were granted under the 2021 Plan during the nine months ended September 30, 2023. Stock option activity under the 2021 Plan for the nine months ended September 30, 2023 was as follows: Number of Weighted Average Aggregate Weighted Average Outstanding at January 1, 2023 5 $ 39.52 $ — 9.61 Forfeited or expired — 32.08 Outstanding at March 31, 2023 5 $ 39.55 $ — 9.38 Forfeited or expired — 38.31 Outstanding at June 30, 2023 5 $ 39.56 $ — 9.14 Forfeited or expired — 16.26 Outstanding at September 30, 2023 5 $ 39.58 $ — 8.88 Vested and exercisable 2 $ 39.56 $ — 8.87 As of September 30, 2023 , there was $ 68 of total unrecognized compensation cost related to stock options granted under the 2021 Plan. That cost is expected to be recognized over a weighted-average period of 2.61 years. Restricted Stock Units and Performance Stock Units RSU and PSU activity under the 2021 Plan for the nine months ended September 30, 2023 was as follows: Number of Weighted Average Total Fair Value Unvested at January 1, 2023 103 $ 25.92 Granted 32 9.65 $ 305 Vested ( 18 ) 18.79 $ 188 Forfeited ( 24 ) 20.07 Unvested at March 31, 2023 93 17.81 Vested ( 26 ) 11.88 $ 199 Forfeited ( 17 ) 18.61 Unvested at June 30, 2023 50 20.69 Granted 181 6.20 $ 1,128 Vested ( 48 ) 7.52 $ 323 Forfeited ( 1 ) 9.18 Unvested at September 30, 2023 182 $ 9.77 As of September 30, 2023, there was $ 1,432 total unrecognized compensation cost related to unvested RSUs and $ 72 total unrecognized compensation cost related to performance and market-based PSUs granted under the 2021 Plan. The total cost is expected to be recognized over a weighted-average period of 1.94 years. 2018 Plan The 2018 Plan became effective on April 17, 2018. The 2018 Plan terminated upon closing of the Business Combination in 2022, but then-outstanding options under the 2018 Plan remain outstanding pursuant to their terms, with adjustments to the number of shares and exercise prices to reflect the terms of the Business Combination. The fair value of each stock option award to employees is estimated on the date of grant using the Black-Scholes option pricing model. There were no grants made in 2023 or 2022 under the 2018 Plan. Stock option activity under the 2018 Plan for the periods presented was as follows: Number of Weighted Average Aggregate Weighted Average Outstanding at January 1, 2023 172 $ 32.06 Exercised — 8.00 Forfeited or expired ( 22 ) 27.97 Outstanding at March 31, 2023 150 32.68 Forfeited or expired ( 26 ) 25.50 Outstanding at June 30, 2023 124 34.17 Forfeited or expired ( 7 ) 31.57 Outstanding at September 30, 2023 1 117 $ 34.29 $ 8 4.90 Vested and exercisable 53 $ 26.91 $ 8 5.98 1. Includes 64 and 53 awards accounted for as service-based and market-based options, respectively, that are vested, that the Company currently deems probable of vesting, or in the case of market-based options, that the Company is expensing so long as the respective service conditions are met. The market-based options will vest only if the price of the Company's common stock reaches a $ 1 billion market capitalization target for any 20 days during a 30 -day period on or before February 4, 2026. As of September 30, 2023, ther e was: (i) $ 363 of unrecognized compensation cost related to service-based 2018 Plan option awards, which is expected to be recognized over a remaining weighted-average service period of approximately 1.63 years; and (ii) $ 585 of unrecognized compensation cost related to market-based 2018 Plan option awards, which is expected to be recognized over a remaining weighted-average service period of approximately 0.57 years. Stock-Based Compensation Expense The following table presents the classification of stock-based compensation expense under the 2021 Plan, the 2018 Plan and the ESPP: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Sales and marketing $ 94 $ 77 $ 230 $ 137 Product development 141 86 347 123 General and administrative 762 608 1,658 2,899 $ 997 $ 771 $ 2,235 $ 3,159 2022 Option Modification Concurrent with the closing of the Business Combination, the vesting provisions of certain stock options previously granted in 2021 under the 2018 Pl an to our Chief Executive Officer to purchase 146 shares of common stock were modified, and a corresponding charge of $ 1,366 was recorded during the three months ended March 31, 2022 to general and administrative expenses and additional paid-in capital. Employee Stock Purchase Plan The ESPP became effective immediately upon closing of the Business Combination. Pursuant to the ESPP, 56 shares of common stock were initially reserved for issuance. During the term of the ESPP, the number of shares of common stock thereunder automatically increases on each January 1, commencing on January 1, 2023 and ending on (and including) January 1, 2031, by the lesser of (i) 2.5 % of the fully diluted shares of common stock as of the last day of the preceding fiscal year and (ii) 56 shares (as adjusted pursuant to the terms of the ESPP). Effective January 1, 2023, 55 shares of common stock were available for issuance under the ESPP and 35 remained available at September 30, 2023 . On March 15, 2023, eligible employees purchased 14 shares for a total purchase price of $ 120 . On September 15, 2023, eligible employees purchased 6 shares for a total purchase price of $ 49 . The Company's current offering period runs from September 16, 2023 through March 15, 2024. Stock-based compensation expense includes $ 11 and $ 78 related to the ESPP for the three and nine months ended September 30, 2023 and $ 12 for both the three and nine months ended September 30, 2022. Earn-Out Plan The Earn-Out Plan became effective immediately upon closing of the Business Combination. Pursuant to the Earn-Out Plan, approximately 29 shares of common stock have been reserved for issuance to employees and certain other eligible parties in the form of RSUs. These RSUs will vest if the Company achieves certain thresholds prior to the third anniversary of the closing of the Business Combination. No RSUs have been awarded under the Earn-Out Plan as of September 30, 2023. Defined Contribution Plan The Company recognized expense from matching contributions to the Company-sponsored defined contribution retirement (401k) plan as follows for the periods presented: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 401(k) matching contributions $ 134 $ 225 $ 520 $ 684

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 15 — Related Pa rty Transactions In June 2021, Merida Capital, an affiliate of Merida, purchased a convertible promissory note totaling $ 1,000 . The note was issued as part of the existing series of 2021 Notes (see Note 11 ) and was subject to the same interest rate, maturity, and conversion terms. This note converted to shares of Leafly common stock upon closing of the Business Combination in February 2022, along with the other 2021 Notes. At December 31, 2022 , the Company owed $ 10 to two members of its Board, which is included in accrued expenses and other current liabilities on Leafly's consolidated balance sheet and was repaid during the first quarter of 2023. Effective September 1, 2023, the Company entered into a consulting agreement with Peter Lee, a member of the Company’s Board of Directors, at a rate of $ 30 per month for an initial term of two months, extendable for a second term of two months, for a total maximum term of four months. Under the agreement, Mr. Lee is providing the Company with certain consultancy services related to the Company’s business strategies.

Net (Loss) Income Per Share

Net (Loss) Income Per Share	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Net (Loss) Income Per Share	NOTE 16 — Net (Loss) Income Per Share Basic and diluted net (loss) income per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. Under the two-class method, basic net (loss) income per share attributable to common stockholders is computed by dividing the net (loss) income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Shares repurchased and held in treasury by the Company are removed from the weighted-average number of shares of common stock outstanding as of the date of repurchase. The Company considers its preferred stock to be participating securities. As of September 30, 2023 and September 30, 2022, the Company ha d 81 outstanding shares of common stock that are in escrow and subject to earn-out conditions and thus forfeiture, which do not meet the criteria for participating securities (see Note 12 for additional information). Net (loss) income is attributed to common stockholders and participating securities based on their participation rights. Net loss is not attributed to the preferred stock as the holders of the preferred stock do not have a contractual obligation to share in any losses. Diluted earnings per share attributable to common stockholders adjusts basic earnings per share for the potentially dilutive impact of non-participating shares of common stock that are subject to forfeiture, stock options, preferred stock, convertible notes, and other securities outstanding. Certain securities are antidilutive and as such, are excluded from the calculation of diluted earnings per share and disclosed separately. Because of the nature of the calculation, particular securities may be dilutive in some periods and anti-dilutive in other periods. The Class 1, 2, and 3 common shares presented below have been retroactively restated for all periods using the conversion ratio in connection with the Business Combination. The following table presents the computation of basic and diluted net (loss) income per share attributable to common stockholders, as a group, for the periods presented: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Net (loss) income $ ( 2,210 ) $ 15,454 $ ( 9,043 ) $ 10,837 Income impact of FPAs — ( 3,939 ) — ( 346 ) Income impact of convertible promissory notes — 600 — — Total undistributed (loss) income $ ( 2,210 ) $ 12,115 $ ( 9,043 ) $ 10,491 Weighted average shares outstanding 2,011 1,779 1,974 1,763 Dilutive effect of FPAs — 177 — 57 Dilutive effect of convertible promissory notes — 124 — — Dilutive effect of stock-based awards — 69 — 104 Common stock and common stock equivalents 2,011 2,149 1,974 1,924 Basic net (loss) income per share $ ( 1.10 ) $ 8.69 $ ( 4.58 ) $ 6.15 Diluted net (loss) income per share $ ( 1.10 ) $ 5.64 $ ( 4.58 ) $ 5.45 The following shares of common stock subject to certain instruments were excluded from the computation of diluted net income per share attributable to common stockholders for the periods presented as their effect would have been antidilutive (with figures recast using the conversion ratio for the Business Combination, as applicable): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Shares subject to warrants 523 523 523 523 Shares subject to convertible promissory notes 124 — 124 121 Shares subject to ESPP 13 14 11 14 Escrow Shares 81 81 81 81 Shares subject to outstanding common stock options, RSUs and PSUs 285 56 240 56 Shares subject to stockholder earn-out rights 271 271 271 271 1,297 945 1,250 1,066 See Note 11 for additional information regarding convertible promissory notes, Note 12 for additional information regarding stockholder earn-out rights, preferred stock, and Escrow Shares, Note 13 for additional information regarding warrants, and Note 14 for additional information regarding stock options, RSUs and PSUs.

Segment Reporting

Segment Reporting	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Segment Reporting	NOTE 17 — Segm ent Reporting Segment revenue and gross profit were as follows during the periods presented: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenue: Retail $ 9,266 $ 9,042 $ 27,576 $ 27,286 Brands 1,317 2,739 4,931 7,965 Total revenue $ 10,583 $ 11,781 $ 32,507 $ 35,251 Gross profit: Retail $ 8,234 $ 7,916 $ 24,374 $ 23,975 Brands 1,186 2,350 4,386 6,865 Total gross profit $ 9,420 $ 10,266 $ 28,760 $ 30,840 Assets are not allocated to segments for internal reporting presentations, nor are depreciation and amortization. Geographic Areas The Company’s operations are primarily in the U.S. and to a lesser extent, in Canada. Refer to Note 9 for revenue classified by major geographic area.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	NOTE 18 — Fair Valu e Measurements The Company follows the guidance in ASC 820, “Fair Value Measurement,” for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1 : Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 : Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3 : Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The Company’s financial instruments include cash equivalents, restricted cash, accounts receivable from customers, accounts payable and accrued liabilities, all of which are typically short-term in nature. The Company believes that the carrying amounts of these financial instruments reasonably approximate their fair values due to their short-term nature. The following table presents information about the Company’s derivative liabilities that are measured at fair value on a recurring basis beginning February 4, 2022 (the date of closing of the Business Combination) when the derivative liabilities were assumed, and discloses the fair value hierarchy level of the valuation inputs the Company utilized to determine such fair value: Fair Value at Change in Fair Description Level September 30, 2023 June 30, 2023 December 31, 2022 September 30, 2022 June 30, 2022 Three Months Ended Three Months Ended Nine Months Ended September 30, 2023 Nine Months Ended September 30, 2022 Private Warrants derivative liability 3 $ 113 $ 121 $ 182 $ 662 $ 3,693 $ 8 $ 3,031 $ 69 $ 3,254 Forward share purchase agreements derivative liability 1 3 — — — — 17,763 — 3,940 — 346 Escrow Shares derivative liability 3 5 6 52 47 3,481 1 3,434 47 6,821 Stockholder earn-out rights derivative liability 3 25 30 204 288 12,147 5 11,859 179 25,843 Total $ 143 $ 157 $ 438 $ 997 $ 37,084 $ 14 $ 22,264 $ 295 $ 36,264 1. The forward share purchase agreements were settled effective August 1, 2022, at which time the fair value was $ 13,824 based on cash settlement. Assumptions used to determine the fair values are presented in the following sections: Private Warrants Derivative Liability The Private Warrants were valued using a Black-Scholes model and the following Level 3 inputs: September 30, 2023 June 30, 2023 December 31, 2022 September 30, 2022 June 30, 2022 Exercise price $ 230.00 $ 230.00 $ 230.00 $ 230.00 $ 230.00 Stock price $ 6.42 $ 5.80 $ 13.00 $ 13.60 $ 90.00 Volatility 99.9 % 99.9 % 75.0 % 98.0 % 51.6 % Term (in years) 3.35 3.60 4.09 4.34 4.59 Risk-free rate 4.7 % 4.5 % 4.1 % 4.1 % 3.0 % Dividend yield 0.0 % 0.0 % 0.0 % 0.0 % 0.0 % The volatility input was calculated using a weighted average of historical volatilities from select benchmark companies and the volatility of the Public Warrants. The term input represents the maximum contractual term, though the Private Warrants may be exercised earlier. The interest rate input is the U.S. Treasury constant maturity rate for the instrument that most closely matches the term input. Forward Share Purchase Agreements Derivative Liability The FPAs were valued using a Black-Scholes model and the following Level 3 inputs: June 30, 2022 Exercise price - one agreement $ 206.20 Exercise price - three agreements $ 203.20 Stock price $ 90.00 Volatility 70.4 % Term (in years) 0.09 Risk-free rate 1.3 % Dividend yield 0.0 % The volatility input was calculated using a weighted average of historical volatilities from select benchmark companies. The term input represents the maximum contractual term, though the shares underlying the FPAs were in some cases sold by the holders into the open market earlier (see Note 13 ). The interest rate input is the U.S. Treasury constant maturity rate for the instrument that most closely matches the term input. Escrow Shares Derivative Liability The Escrow Shares derivative liability was calculated using a Monte Carlo simulation and the following Level 3 inputs: September 30, 2023 June 30, 2023 December 31, 2022 September 30, 2022 June 30, 2022 First stock price trigger $ 270.00 $ 270.00 $ 270.00 $ 270.00 $ 270.00 Second stock price trigger $ 310.00 $ 310.00 $ 310.00 $ 310.00 $ 310.00 Stock price $ 6.42 $ 5.80 $ 13.00 $ 13.60 $ 90.00 Volatility 98.6 % 98.6 % 86.0 % 79.0 % 68.0 % Term (in years) 1.35 1.60 2.09 2.34 2.59 Risk-free rate 5.4 % 5.1 % 4.4 % 4.2 % 3.0 % Dividend yield 0.0 % 0.0 % 0.0 % 0.0 % 0.0 % The volatility input was calculated using a weighted average of historical volatilities from select benchmark companies. The term input represents the maximum contractual term, though the shares may be released from escrow earlier. The interest rate input is the U.S. Treasury constant maturity rate for the instrument that most closely matches the term input. Stockholder Earn-Out Rights Derivative Liability The stockholder earn-out rights were valued using a Monte Carlo simulation and the following Level 3 inputs: September 30, 2023 June 30, 2023 December 31, 2022 September 30, 2022 June 30, 2022 First stock price trigger $ 270.00 $ 270.00 $ 270.00 $ 270.00 $ 270.00 Second stock price trigger $ 310.00 $ 310.00 $ 310.00 $ 310.00 $ 310.00 First revenue trigger $ 65,000 $ 65,000 $ 65,000 $ 65,000 $ 65,000 Second revenue trigger $ 101,000 $ 101,000 $ 101,000 $ 101,000 $ 101,000 Stock price $ 6.42 $ 5.80 $ 13.00 $ 13.60 $ 90.00 Base year revenue assumption $ 42,000 $ 44,000 $ 48,000 $ 47,500 $ 49,500 Volatility 98.6 % 98.6 % 86.0 % 79.0 % 68.0 % Term (in years) 1.35 1.60 2.09 2.34 2.59 Risk-free rate 5.4 % 5.1 % 4.4 % 4.2 % 3.0 % Dividend yield 0.0 % 0.0 % 0.0 % 0.0 % 0.0 % The revenue assumption input relates to projected revenue for fiscal year 2022 (for the periods ended September 30, 2022 and June 30, 2022) and fiscal year 2023 (for the periods ended September 30, 2023 and June 30, 2023) and represents the midpoint of revenue guidance the Company provided in the respective periods. The volatility input was calculated using a weighted average of historical volatilities from select benchmark companies. The term input represents the maximum contractual term, though the stockholder earn-out rights may vest earlier. The interest rate input is the U.S. Treasury constant maturity rate for the instrument that most closely matches the term input.

Basis of Presentation and Sig_2

Basis of Presentation and Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The interim condensed consolidated financial statements have been prepared in accordance with GAAP and the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting and should be read in conjunction with the Company's audited consolidated financial statements for the years ended December 31, 2022 and 2021, and Management’s Discussion and Analysis of Financial Condition and Results of Operations of Leafly for the year ended December 31, 2022, each of which was filed with the SEC on March 29, 2023 (the “2022 Financial Information”). These condensed consolidated financial statements are unaudited and, in management's opinion, include all adjustments, consisting of normal recurring estimates and accruals necessary for a fair presentation of our consolidated cash flows, operating results, and balance sheets for the periods presented. Actual results may differ from these estimates and assumptions. The results of operations for any interim periods are not necessarily indicative of the results that may be expected for the entire fiscal year or any other interim period. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with GAAP have been omitted in accordance with the rules and regulations o f the SEC for interim reporting. All intercompany balances and transactions have been eliminated upon consolidation. Going Concern Evaluation Under the rules of ASC Subtopic 205-40 “Presentation of Financial Statements-Going Concern” (“ASC 205-40”), reporting companies are required to evaluate whether conditions and/or events raise substantial doubt about their ability to meet their future financial obligations as they become due within one year after the date that the financial statements are issued. This evaluation takes into account a company’s current available cash and projected cash needs over the one-year evaluation period but may not consider things beyond its control. Leafly has experienced revenue declines, incurred recurring operating losses, used cash from operations, and relied on the capital raised in the Business Combination to continue ongoing operations. These conditions, when considered in the aggregate, raise substantial doubt about Leafly’s ability to continue as a going concern within one year of the date these financial statements are issued. In response to these conditions, Leafly management took the following actions: • During the fourth quarter of 2022, Leafly implemented a restructuring plan, including a reduction in force reflecting primarily one-time severance and other employee-related termination benefits incurred during the fourth quarter of 2022. • During the three months ended March 31, 2023, Leafly announced a second restructuring plan further seeking to reduce recurring costs and operating expenditures and identifying cost savings based on a reduction in force reflecting primarily one-time severance and other employee-related termination benefits incurred during the first quarter of 2023. The restructuring plans above have been implemented and are expected to continue contributing to the cash savings of the Company. The Company’s management is closely monitoring and reducing operating expenses where it is able to, while ensuring the trajectory and viability of the business remains intact. After considering all available evidence, Leafly’s management determined that, based on the cost reduction measures outlined in both actions above, Leafly’s current positive working capital will be sufficient to meet its capital requirements for a period of at least 12 months from the date that these September 30, 2023 financial statements are issued.
Consolidation	All intercompany balances and transactions have been eliminated upon consolidation.
Reverse Stock Split	Reverse Stock Split On September 12, 2023, the Company implemented a one-for-twenty reverse split of its common stock ( Note 12 ). To facilitate comparative analysis, all statements in this Quarterly Report regarding numbers of shares of common stock and all references to prices of a share of common stock, if referencing events or circumstances occurring prior to September 12, 2023, have been retroactively restated to reflect the effect of the reverse stock split on a pro forma basis.
Reclassifications	Reclassifications Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no effect on the reported net (loss) income.
Seasonality	Seasonality We may experience seasonality in our business, which we believe has moderate impacts on our overall revenue. In certain years, we've seen seasonal fluctuations that coincide with either federal holidays, generally in the fourth quarter, or industry holidays and events, generally in the spring. Our industry and business history is limited and therefore we cannot be certain that these are known trends or that other trends may develop.
Emerging Growth Company Status	Emerging Growth Company Status Leafly is an emerging growth company (“EGC”), as defined in the Jumpstart Our Business Startups Act (“JOBS Act”). Under the JOBS Act, EGCs can delay adopting new or revised accounting standards issued until such time as those standards apply to private companies. The Company has elected to use this extended transition period. In providing this relief, the JOBS Act does not preclude the Company from adopting a new or revised accounting standard earlier than the time that such standard applies to private companies. Leafly will continue to use this relief until the earlier of the date that it (a) is no longer an EGC or (b) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act.
Use of Estimates	These condensed consolidated financial statements are unaudited and, in management's opinion, include all adjustments, consisting of normal recurring estimates and accruals necessary for a fair presentation of our consolidated cash flows, operating results, and balance sheets for the periods presented. Actual results may differ from these estimates and assumptions. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses in the condensed consolidated financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates. Such estimates include those related to the fair value of derivative liabilities; the allowance for doubtful accounts; the valuation allowance for deferred income tax assets; the fair value of the convertible promissory notes; the estimate of capitalized software costs and useful life of capitalized software; and the fair value of equity issuances. Management bases its estimates on historical experience, knowledge of current events and actions it may undertake in the future that management believes to be reasonable under the circumstances. Actual results may differ from these estimates and assumptions.
Significant Accounting Policies	Significant Accounting Policies The unaudited interim financial statements should be read in conjunction with the Company's 2022 Financial Information, which describes the Company's significant accounting policies. There have been no material changes to the Company's significant accounting policies during the nine months ended September 30, 2023 compared to our 2022 Annual Report.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Accounting Pronouncements Issued But Not Yet Adopted Management does not believe that there are any recently issued, but not yet effective, accounting standards that, if currently adopted, would have a material effect on the Company’s consolidated financial statements or related disclosures.

Cash, Cash Equivalents, and R_2

Cash, Cash Equivalents, and Restricted Cash (Tables)	9 Months Ended
	Sep. 30, 2023
Cash and Cash Equivalents [Abstract]
Schedule of Cash and Cash Equivalents	Cash, cash equivalents, and restricted cash consisted of the following: September 30, 2023 December 31, 2022 Cash and cash equivalents $ 14,469 $ 24,594 Restricted cash — 360 Restricted cash - long-term portion 249 248 $ 14,718 $ 25,202

Prepaid Expenses and Other As_2

Prepaid Expenses and Other Assets (Tables)	9 Months Ended
	Sep. 30, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Prepaid Expenses and Other Assets	Prepaid expenses and other assets consist of the following: September 30, 2023 December 31, 2022 Prepaid subscriptions $ 703 $ 916 Prepaid insurance 1,277 533 Other prepaid assets 186 272 Other current assets 173 71 Subtotal, current portion 2,339 1,792 Prepaid expenses, long-term portion 55 135 Total $ 2,394 $ 1,927

Accounts Receivable, Net (Table

Accounts Receivable, Net (Tables)	9 Months Ended
	Sep. 30, 2023
Receivables [Abstract]
Schedule of Allowance for Doubtful Accounts	The following table presents the allowance for doubtful accounts and the changes therein: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Balance, beginning of period $ 1,404 $ 1,469 $ 908 $ 1,848 Add: provision for doubtful accounts, net of recoveries 940 383 2,350 1,023 Less: write-offs ( 944 ) ( 894 ) ( 1,858 ) ( 1,913 ) Balance, end of period $ 1,400 $ 958 $ 1,400 $ 958

Property, Equipment, and Softwa

Property, Equipment, and Software, Net (Tables)	9 Months Ended
	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property, equipment, and software consisted of the following: September 30, 2023 December 31, 2022 Furniture and equipment $ 454 $ 740 Capitalized internal-use software 3,352 2,310 3,806 3,050 Less: accumulated depreciation and amortization ( 1,265 ) ( 765 ) $ 2,541 $ 2,285
Schedule Of Depreciation and Amortization Expense	The Company recognized depreciation and amortization expense as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Depreciation expense $ 21 $ 37 $ 68 $ 135 Amortization of capitalized internal-use software 255 90 629 141 Total depreciation and amortization $ 276 $ 127 $ 697 $ 276 During the nine months ended September 30, 2023 , the Company disposed of equipment with a book value of $ 90 for $ 27 , resulting in a loss on disposal of $ 63 . During the three months ended September 30, 2023 , the Company disposed of equipment with a book value of $ 88 for $ 16 , resulting in a loss on disposal of $ 72 .

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	9 Months Ended
	Sep. 30, 2023
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses consisted of the following: September 30, 2023 December 31, 2022 Accrued bonuses $ 922 $ 1,309 Other employee-related liabilities 1,068 2,403 Accrued interest 400 1,000 Other accrued expenses 1 600 1,523 $ 2,990 $ 6,235 1. There are no individual items within this balance that exceed 10% of the total of the table .

Revenue and Contract Balances (

Revenue and Contract Balances (Tables)	9 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table presents the Company's revenue by service type: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Advertising 1 $ 10,386 $ 11,731 $ 32,126 $ 34,914 Other services 1 197 50 381 337 $ 10,583 $ 11,781 $ 32,507 $ 35,251 1. Amounts for the prior period have been reclassified to conform to the current period presentation. The following table presents the Company's revenue by geographic region: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 United States 1 $ 10,155 $ 11,140 $ 31,213 $ 32,742 All other countries 1 428 641 1,294 2,509 $ 10,583 $ 11,781 $ 32,507 $ 35,251 1. Amounts for the prior period have been reclassified to conform to the current period presentation. The following table presents the Company's revenue by state: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Arizona 20 % 19 % 20 % 18 % California 12 % 13 % 12 % 11 % Oregon 11 % 10 % 11 % 10 % The following table presents the Company's revenue by timing of recognition: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Over Time 1 Retail 2 $ 9,266 $ 9,042 $ 27,576 $ 27,286 Brands 3 929 1,758 3,571 5,067 10,195 10,800 31,147 32,353 Point in time 1 Brands 4 388 981 1,360 2,898 $ 10,583 $ 11,781 $ 32,507 $ 35,251 1. Amounts for the prior period have been reclassified to conform to the current period presentation. 2. Revenues from subscription services and display ads. 3. Revenues from brand profile subscriptions and digital media (including display ads and audience extension). 4. Revenues from channel advertising (including direct to consumer email).
Schedule of Deferred Revenue	The following table presents the Company's deferred revenue balances and changes therein: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Balance, beginning of period $ 2,017 $ 2,467 $ 1,958 $ 1,975 Add: net increase in current period contract liabilities 1,991 1,630 2,083 1,976 Less: revenue recognized from beginning balance ( 1,913 ) ( 2,045 ) ( 1,946 ) ( 1,899 ) Balance, end of period $ 2,095 $ 2,052 $ 2,095 $ 2,052

Equity Incentive and Other Pl_2

Equity Incentive and Other Plans (Tables)	9 Months Ended
	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	Stock option activity under the 2021 Plan for the nine months ended September 30, 2023 was as follows: Number of Weighted Average Aggregate Weighted Average Outstanding at January 1, 2023 5 $ 39.52 $ — 9.61 Forfeited or expired — 32.08 Outstanding at March 31, 2023 5 $ 39.55 $ — 9.38 Forfeited or expired — 38.31 Outstanding at June 30, 2023 5 $ 39.56 $ — 9.14 Forfeited or expired — 16.26 Outstanding at September 30, 2023 5 $ 39.58 $ — 8.88 Vested and exercisable 2 $ 39.56 $ — 8.87 Stock option activity under the 2018 Plan for the periods presented was as follows: Number of Weighted Average Aggregate Weighted Average Outstanding at January 1, 2023 172 $ 32.06 Exercised — 8.00 Forfeited or expired ( 22 ) 27.97 Outstanding at March 31, 2023 150 32.68 Forfeited or expired ( 26 ) 25.50 Outstanding at June 30, 2023 124 34.17 Forfeited or expired ( 7 ) 31.57 Outstanding at September 30, 2023 1 117 $ 34.29 $ 8 4.90 Vested and exercisable 53 $ 26.91 $ 8 5.98 1. Includes 64 and 53 awards accounted for as service-based and market-based options, respectively, that are vested, that the Company currently deems probable of vesting, or in the case of market-based options, that the Company is expensing so long as the respective service conditions are met. The market-based options will vest only if the price of the Company's common stock reaches a $ 1 billion market capitalization target for any 20 days during a 30 -day period on or before February 4, 2026.
Schedule of Restricted Stock Unit Activity	RSU and PSU activity under the 2021 Plan for the nine months ended September 30, 2023 was as follows: Number of Weighted Average Total Fair Value Unvested at January 1, 2023 103 $ 25.92 Granted 32 9.65 $ 305 Vested ( 18 ) 18.79 $ 188 Forfeited ( 24 ) 20.07 Unvested at March 31, 2023 93 17.81 Vested ( 26 ) 11.88 $ 199 Forfeited ( 17 ) 18.61 Unvested at June 30, 2023 50 20.69 Granted 181 6.20 $ 1,128 Vested ( 48 ) 7.52 $ 323 Forfeited ( 1 ) 9.18 Unvested at September 30, 2023 182 $ 9.77
Schedule of Stock-Based Compensation Expense	The following table presents the classification of stock-based compensation expense under the 2021 Plan, the 2018 Plan and the ESPP: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Sales and marketing $ 94 $ 77 $ 230 $ 137 Product development 141 86 347 123 General and administrative 762 608 1,658 2,899 $ 997 $ 771 $ 2,235 $ 3,159
Summary of Defined Contribution Retirement (401k) Plan	The Company recognized expense from matching contributions to the Company-sponsored defined contribution retirement (401k) plan as follows for the periods presented: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 401(k) matching contributions $ 134 $ 225 $ 520 $ 684

Net (Loss) Income Per Share (Ta

Net (Loss) Income Per Share (Tables)	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Schedule of Computation Basic and Diluted Net (Loss) Income Per Share	The following table presents the computation of basic and diluted net (loss) income per share attributable to common stockholders, as a group, for the periods presented: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Net (loss) income $ ( 2,210 ) $ 15,454 $ ( 9,043 ) $ 10,837 Income impact of FPAs — ( 3,939 ) — ( 346 ) Income impact of convertible promissory notes — 600 — — Total undistributed (loss) income $ ( 2,210 ) $ 12,115 $ ( 9,043 ) $ 10,491 Weighted average shares outstanding 2,011 1,779 1,974 1,763 Dilutive effect of FPAs — 177 — 57 Dilutive effect of convertible promissory notes — 124 — — Dilutive effect of stock-based awards — 69 — 104 Common stock and common stock equivalents 2,011 2,149 1,974 1,924 Basic net (loss) income per share $ ( 1.10 ) $ 8.69 $ ( 4.58 ) $ 6.15 Diluted net (loss) income per share $ ( 1.10 ) $ 5.64 $ ( 4.58 ) $ 5.45
Schedule of Antidilutive Shares	The following shares of common stock subject to certain instruments were excluded from the computation of diluted net income per share attributable to common stockholders for the periods presented as their effect would have been antidilutive (with figures recast using the conversion ratio for the Business Combination, as applicable): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Shares subject to warrants 523 523 523 523 Shares subject to convertible promissory notes 124 — 124 121 Shares subject to ESPP 13 14 11 14 Escrow Shares 81 81 81 81 Shares subject to outstanding common stock options, RSUs and PSUs 285 56 240 56 Shares subject to stockholder earn-out rights 271 271 271 271 1,297 945 1,250 1,066

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Schedule of Segment Revenue and Gross Profit	Segment revenue and gross profit were as follows during the periods presented: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenue: Retail $ 9,266 $ 9,042 $ 27,576 $ 27,286 Brands 1,317 2,739 4,931 7,965 Total revenue $ 10,583 $ 11,781 $ 32,507 $ 35,251 Gross profit: Retail $ 8,234 $ 7,916 $ 24,374 $ 23,975 Brands 1,186 2,350 4,386 6,865 Total gross profit $ 9,420 $ 10,266 $ 28,760 $ 30,840

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following table presents information about the Company’s derivative liabilities that are measured at fair value on a recurring basis beginning February 4, 2022 (the date of closing of the Business Combination) when the derivative liabilities were assumed, and discloses the fair value hierarchy level of the valuation inputs the Company utilized to determine such fair value: Fair Value at Change in Fair Description Level September 30, 2023 June 30, 2023 December 31, 2022 September 30, 2022 June 30, 2022 Three Months Ended Three Months Ended Nine Months Ended September 30, 2023 Nine Months Ended September 30, 2022 Private Warrants derivative liability 3 $ 113 $ 121 $ 182 $ 662 $ 3,693 $ 8 $ 3,031 $ 69 $ 3,254 Forward share purchase agreements derivative liability 1 3 — — — — 17,763 — 3,940 — 346 Escrow Shares derivative liability 3 5 6 52 47 3,481 1 3,434 47 6,821 Stockholder earn-out rights derivative liability 3 25 30 204 288 12,147 5 11,859 179 25,843 Total $ 143 $ 157 $ 438 $ 997 $ 37,084 $ 14 $ 22,264 $ 295 $ 36,264 1. The forward share purchase agreements were settled effective August 1, 2022, at which time the fair value was $ 13,824 based on cash settlement.
Schedule of Valuation Assumptions	The Private Warrants were valued using a Black-Scholes model and the following Level 3 inputs: September 30, 2023 June 30, 2023 December 31, 2022 September 30, 2022 June 30, 2022 Exercise price $ 230.00 $ 230.00 $ 230.00 $ 230.00 $ 230.00 Stock price $ 6.42 $ 5.80 $ 13.00 $ 13.60 $ 90.00 Volatility 99.9 % 99.9 % 75.0 % 98.0 % 51.6 % Term (in years) 3.35 3.60 4.09 4.34 4.59 Risk-free rate 4.7 % 4.5 % 4.1 % 4.1 % 3.0 % Dividend yield 0.0 % 0.0 % 0.0 % 0.0 % 0.0 % The FPAs were valued using a Black-Scholes model and the following Level 3 inputs: June 30, 2022 Exercise price - one agreement $ 206.20 Exercise price - three agreements $ 203.20 Stock price $ 90.00 Volatility 70.4 % Term (in years) 0.09 Risk-free rate 1.3 % Dividend yield 0.0 % The Escrow Shares derivative liability was calculated using a Monte Carlo simulation and the following Level 3 inputs: September 30, 2023 June 30, 2023 December 31, 2022 September 30, 2022 June 30, 2022 First stock price trigger $ 270.00 $ 270.00 $ 270.00 $ 270.00 $ 270.00 Second stock price trigger $ 310.00 $ 310.00 $ 310.00 $ 310.00 $ 310.00 Stock price $ 6.42 $ 5.80 $ 13.00 $ 13.60 $ 90.00 Volatility 98.6 % 98.6 % 86.0 % 79.0 % 68.0 % Term (in years) 1.35 1.60 2.09 2.34 2.59 Risk-free rate 5.4 % 5.1 % 4.4 % 4.2 % 3.0 % Dividend yield 0.0 % 0.0 % 0.0 % 0.0 % 0.0 % The stockholder earn-out rights were valued using a Monte Carlo simulation and the following Level 3 inputs: September 30, 2023 June 30, 2023 December 31, 2022 September 30, 2022 June 30, 2022 First stock price trigger $ 270.00 $ 270.00 $ 270.00 $ 270.00 $ 270.00 Second stock price trigger $ 310.00 $ 310.00 $ 310.00 $ 310.00 $ 310.00 First revenue trigger $ 65,000 $ 65,000 $ 65,000 $ 65,000 $ 65,000 Second revenue trigger $ 101,000 $ 101,000 $ 101,000 $ 101,000 $ 101,000 Stock price $ 6.42 $ 5.80 $ 13.00 $ 13.60 $ 90.00 Base year revenue assumption $ 42,000 $ 44,000 $ 48,000 $ 47,500 $ 49,500 Volatility 98.6 % 98.6 % 86.0 % 79.0 % 68.0 % Term (in years) 1.35 1.60 2.09 2.34 2.59 Risk-free rate 5.4 % 5.1 % 4.4 % 4.2 % 3.0 % Dividend yield 0.0 % 0.0 % 0.0 % 0.0 % 0.0 %

Description of the Business a_2

Description of the Business and Merger - Significant Sources and Uses of Cash (Details)	Feb. 04, 2022
Convertible Senior Notes | 2021 Notes
Schedule Of Reverse Recapitalization [Line Items]
Conversion ratio	0.0164

Cash, Cash Equivalents, and R_3

Cash, Cash Equivalents, and Restricted Cash - Schedule of Cash and Cash Equivalents (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2021
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents	$ 14,469	$ 24,594
Restricted cash	0	360
Restricted cash - long-term portion	249	248
Cash, cash equivalents, and restricted cash	$ 14,718	$ 25,202	$ 28,436	$ 28,695

Cash, Cash Equivalents, and R_4

Cash, Cash Equivalents, and Restricted Cash - Narrative (Details) - USD ($) shares in Thousands, $ in Thousands	Aug. 01, 2022	Sep. 30, 2023	Jul. 11, 2023	Dec. 31, 2022	Feb. 04, 2022
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash		$ 0		$ 360
Common Stock
Restricted Cash and Cash Equivalents Items [Line Items]
Purchase of treasury stock (in shares)	154
Purchase of treasury stock	$ 31,663
Escrow deposit
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash			$ 360	$ 360	$ 39,032
Escrow deposit | Common Stock
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash	$ 360

Prepaid Expenses and Other As_3

Prepaid Expenses and Other Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid subscriptions	$ 703	$ 916
Prepaid insurance	1,277	533
Other prepaid assets	186	272
Other current assets	173	71
Subtotal, current portion	2,339	1,792
Prepaid expenses, long-term portion	55	135
Total	$ 2,394	$ 1,927

Accounts Receivable, Net - Narr

Accounts Receivable, Net - Narrative (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Receivables [Abstract]
Accounts receivable, net	$ 3,409	$ 3,298

Accounts Receivable, Net - Sche

Accounts Receivable, Net - Schedule of Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance, beginning of period	$ 1,404	$ 1,469	$ 908	$ 1,848
Add: provision for doubtful accounts, net of recoveries	940	383	2,350	1,023
Less: write-offs	(944)	(894)	(1,858)	(1,913)
Balance, end of period	$ 1,400	$ 958	$ 1,400	$ 958

Property, Equipment, and Soft_2

Property, Equipment, and Software, Net - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 3,806	$ 3,050
Less: accumulated depreciation and amortization	(1,265)	(765)
Property, equipment, and software, net	2,541	2,285
Furniture and equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	454	740
Capitalized Internal Use Software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 3,352	$ 2,310

Property, Equipment, and Soft_3

Property, Equipment, and Software, Net - Schedule Of Depreciation and Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Property, Plant and Equipment [Table]
Depreciation expense	$ 21	$ 37	$ 68	$ 135
Amortization of capitalized internal-use software	255	90	629	141
Total depreciation and amortization	$ 276	$ 127	$ 697	$ 276

Property, Equipment, and Soft_4

Property, Equipment, and Software, Net - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023	Sep. 30, 2022
Property, Plant and Equipment [Line Items]
Proceeds from sale of property and equipment		$ 27	$ 0
Loss on disposal of assets		(63)	$ 0
Equipment
Property, Plant and Equipment [Line Items]
Book value of assets disposed	$ 88	90
Proceeds from sale of property and equipment	16	27
Loss on disposal of assets	$ (72)	$ (63)

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands		Sep. 30, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accrued bonuses		$ 922	$ 1,309
Other employee-related liabilities		1,068	2,403
Accrued interest		400	1,000
Other accrued expenses	[1]	600	1,523
Accrued expenses and other current liabilities		$ 2,990	$ 6,235
[1] There are no individual items within this balance that exceed 10% of the total of the table

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ / shares in Units, $ in Millions	Sep. 12, 2023	Oct. 28, 2022
Reverse stock split	1-for-20
Nasdaq
Securities, Market value		$ 50
Reverse stock split	one-for-twenty
Minimum closing bid price		$ 1

Revenue and Contract Balances -

Revenue and Contract Balances - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 10,583	$ 11,781	$ 32,507	$ 35,251
Retail
Disaggregation of Revenue [Line Items]
Revenue	9,266	9,042	27,576	27,286
Brands
Disaggregation of Revenue [Line Items]
Revenue	1,317	2,739	4,931	7,965
Over Time
Disaggregation of Revenue [Line Items]
Revenue	10,195	10,800	31,147	32,353
Over Time | Retail
Disaggregation of Revenue [Line Items]
Revenue	9,266	9,042	27,576	27,286
Over Time | Brands
Disaggregation of Revenue [Line Items]
Revenue	929	1,758	3,571	5,067
Point in time
Disaggregation of Revenue [Line Items]
Revenue	10,583	11,781	32,507	35,251
Point in time | Brands
Disaggregation of Revenue [Line Items]
Revenue	388	981	1,360	2,898
United States
Disaggregation of Revenue [Line Items]
Revenue	10,155	11,140	31,213	32,742
All other countries
Disaggregation of Revenue [Line Items]
Revenue	$ 428	$ 641	$ 1,294	$ 2,509
Arizona | Revenue | Geographic concentration risk
Disaggregation of Revenue [Line Items]
Concentration risk percentage	20%	19%	20%	18%
California | Revenue | Geographic concentration risk
Disaggregation of Revenue [Line Items]
Concentration risk percentage	12%	13%	12%	11%
Oregon | Revenue | Geographic concentration risk
Disaggregation of Revenue [Line Items]
Concentration risk percentage	11%	10%	11%	10%
Advertising
Disaggregation of Revenue [Line Items]
Revenue	$ 10,386	$ 11,731	$ 32,126	$ 34,914
Other services
Disaggregation of Revenue [Line Items]
Revenue	$ 197	$ 50	$ 381	$ 337

Revenue and Contract Balances_2

Revenue and Contract Balances - Deferred Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Change in Contract with Customer, Liability [Roll Forward]
Balance, beginning of period	$ 2,017	$ 2,467	$ 1,958	$ 1,975
Add: net increase in current period contract liabilities	1,991	1,630	2,083	1,976
Less: revenue recognized from beginning balance	(1,913)	(2,045)	(1,946)	(1,899)
Balance, end of period	$ 2,095	$ 2,052	$ 2,095	$ 2,052

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Operating Loss Carryforwards [Line Items]
Unrecognized tax benefits	$ 0		$ 0		$ 0
Unrecognized tax benefits, accrued interest and penalties	$ 0		$ 0		0
Effective tax rate	0%	0%	0%	0%
Cumulative ownership change	50%		50%
Federal
Operating Loss Carryforwards [Line Items]
Net operating loss carryforward					$ 85,430,000
State
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards expire year begins					2039
Net operating loss carryforward					$ 60,478,000
Foreign
Operating Loss Carryforwards [Line Items]
Net operating loss carryforward					$ 5,801,000

Convertible Promissory Notes (D

Convertible Promissory Notes (Details) $ / shares in Units, shares in Thousands, $ in Thousands		1 Months Ended
	Feb. 04, 2022 $ / shares shares	Jan. 31, 2022 USD ($) Days $ / shares	Sep. 30, 2023 USD ($)	Aug. 31, 2021 USD ($)	Jun. 30, 2021 USD ($)
2022 Notes
Debt Instrument [Line Items]
Aggregate principal amount		$ 1,000
Convertible Senior Notes | 2022 Notes
Debt Instrument [Line Items]
Aggregate principal amount		30,000
Debt issuance costs		714
Debt discount		$ 924
Interest rate		8%
Debt conversion, converted instrument, amount		$ 1,000
Conversion share price (in usd per share) | $ / shares		$ 250
Stock price trigger (in usd per share) | $ / shares		$ 360
Threshold trading days | Days		20
Threshold consecutive trading days | Days		30
Redemption price percentage		100%
Repurchase price percentage		100%
Net carrying amount			$ 29,272
Unamortized issuance costs			728
Convertible Senior Notes | 2022 Notes | Level 3
Debt Instrument [Line Items]
Fair value			$ 27,000
Convertible Senior Notes | 2021 Notes
Debt Instrument [Line Items]
Aggregate principal amount				$ 7,500	$ 23,970
Interest rate				8%
Conversion share price (in usd per share) | $ / shares	$ 52.60
Conversion of stock (in shares) | shares	206
Percent of implied price per share	80%
Conversion ratio	0.0164

Stockholders' Deficit (Details)

Stockholders' Deficit (Details) $ / shares in Units, $ in Thousands				9 Months Ended
	Sep. 12, 2023 shares	Aug. 01, 2022 USD ($) $ / shares shares	Feb. 04, 2022 USD ($) Days $ / shares shares	Sep. 30, 2023 $ / shares shares	Dec. 31, 2022 $ / shares shares	Sep. 30, 2022 shares
Schedule Of Reverse Recapitalization [Line Items]
Reverse stock split	1-for-20
Common stock, authorized (in shares)				200,000,000	200,000,000
Common stock, par value (in usd per share) | $ / shares				$ 0.0001	$ 0.0001
Preferred stock, authorized (in shares)				5,000,000	5,000,000
Preferred stock, par value (in usd per share) | $ / shares				$ 0.0001	$ 0.0001
Preferred stock, issued (in shares)				0	0
Preferred stock, outstanding (in shares)				0	0
Common Stock
Schedule Of Reverse Recapitalization [Line Items]
Reverse stock split ratio	20
Conversion of Stock, Shares Issued	1
Shares canceled				1,000
Purchase of treasury stock (in shares)		154,000
Treasury stock (in usd per share) | $ / shares		$ 205.6
Purchase of treasury stock | $		$ 31,663
Common Stock | Payment using Restricted Cash
Schedule Of Reverse Recapitalization [Line Items]
Purchase of treasury stock | $		31,303
Common Stock | Remaining in Accrued Expenses and Other Current Liabilities
Schedule Of Reverse Recapitalization [Line Items]
Purchase of treasury stock | $		$ 360
Sponsor, escrow shares
Schedule Of Reverse Recapitalization [Line Items]
Earn-out shares (in shares)			81,000	81,000		81,000
Leafly stockholders
Schedule Of Reverse Recapitalization [Line Items]
Reverse stock split on common stock shares aggragated on fractional	34,000
Earn-out shares (in shares)			271,000
Leafly stockholders | Common Stock
Schedule Of Reverse Recapitalization [Line Items]
Reverse stock split ratio	20
Derivative instrument, period, one | Sponsor, escrow shares
Schedule Of Reverse Recapitalization [Line Items]
Earn-out shares, percentage of shares released from escrow			50%
Earn-out shares, earn-out period, stock price trigger (in usd per share) | $ / shares			$ 270
Earn-out shares, earn-out period			2 years
Earn-out shares, threshold trading days | Days			20
Earn-out shares, threshold consecutive trading days			30 days
Derivative instrument, period, one | Leafly stockholders
Schedule Of Reverse Recapitalization [Line Items]
Earn-out shares (in shares)			136,000
Earn-out shares, earn-out period, stock price trigger (in usd per share) | $ / shares			$ 270
Earn-out shares, earn-out period			2 years
Earn-out shares, revenue target | $			$ 65,000
Earn-out shares, threshold trading days | Days			20
Earn-out shares, threshold consecutive trading days			30 days
Earn-out shares, pro rate percentage of shares			50%
Earn-out shares, percentage of revenue target			90%
Derivative instrument, period, two | Sponsor, escrow shares
Schedule Of Reverse Recapitalization [Line Items]
Earn-out shares, percentage of shares released from escrow			50%
Earn-out shares, earn-out period, stock price trigger (in usd per share) | $ / shares			$ 310
Earn-out shares, earn-out period			3 years
Earn-out shares, threshold trading days | Days			20
Earn-out shares, threshold consecutive trading days			30 days
Derivative instrument, period, two | Leafly stockholders
Schedule Of Reverse Recapitalization [Line Items]
Earn-out shares (in shares)			136,000
Earn-out shares, earn-out period, stock price trigger (in usd per share) | $ / shares			$ 310
Earn-out shares, earn-out period			3 years
Earn-out shares, revenue target | $			$ 101,000
Earn-out shares, threshold trading days | Days			20
Earn-out shares, threshold consecutive trading days			30 days
Earn-out shares, pro rate percentage of shares			50%
Earn-out shares, percentage of revenue target			90%

Warrants and Forward Purchase_2

Warrants and Forward Purchase Share Agreements - Warrants (Details)	9 Months Ended
	Sep. 30, 2023 Days $ / shares shares	Dec. 31, 2022 shares
Public Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)	6,501,000	6,501,000
Warrants, exercise price (in usd per share) | $ / shares	$ 230
Warrants, exercisable, period from completion of business combination	30 days
Warrants expiration period	5 years
Redemption price of warrants (in usd per share) | $ / shares	$ 0.2
Redemption notice period	30 days
Redemption stock price trigger (in usd per share) | $ / shares	$ 360
Redemption stock price threshold trading days | Days	20
Redemption stock price threshold consecutive trading days	30 days
Warrants, number of shares converted into by each warrant	0.05
Purchase of common stock	325,000	325,000
Private Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)	3,950,000	3,950,000
Purchase of common stock	198,000	198,000

Warrants and Forward Purchase_3

Warrants and Forward Purchase Share Agreements - Forward Share Purchase Agreements (Details) $ / shares in Units, shares in Thousands, $ in Thousands		2 Months Ended	9 Months Ended	12 Months Ended
	Aug. 01, 2022 USD ($) shares	Jan. 31, 2022 Agreement $ / shares shares	Sep. 30, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($)	Jul. 11, 2023 USD ($)	May 03, 2022 $ / shares shares	Feb. 04, 2022 USD ($)
Derivative [Line Items]
Number of FPAs | Agreement		4
FPAs, number of shares (in shares) | shares		200
Restricted cash			$ 0	$ 360
FPAs, term		3 months
Release of restricted cash from escrow				8,089
Restricted cash			$ 0	360
Common Stock
Derivative [Line Items]
Purchase of treasury stock (in shares) | shares	154
Purchase of treasury stock	$ 31,663
Shares canceled (in shares) | shares			(1)
Escrow deposit
Derivative [Line Items]
Restricted cash				360	$ 360		$ 39,032
Restricted cash				$ 360	$ 360		$ 39,032
Escrow deposit | Common Stock
Derivative [Line Items]
Restricted cash	360
Restricted cash	360
Restricted cash	$ 360
Derivative instrument, period, one
Derivative [Line Items]
FPAs, number of shares (in shares) | shares		130				120
FPAs, exercise price (in usd per share) | $ / shares		$ 203.2				$ 206.2
Derivative instrument, period, two
Derivative [Line Items]
FPAs, number of shares (in shares) | shares			70			34
FPAs, exercise price (in usd per share) | $ / shares			$ 200.2			$ 203.2

Equity Incentive and Other Pl_3

Equity Incentive and Other Plans - Narrative (Details) $ / shares in Units, $ in Thousands							3 Months Ended				9 Months Ended
	Sep. 30, 2023 USD ($) Plan shares		Jul. 25, 2023 shares	Mar. 14, 2023 shares	Mar. 13, 2023 shares	Feb. 04, 2022 USD ($) Days shares	Sep. 30, 2023 USD ($) Plan shares		Dec. 31, 2022 USD ($) $ / shares shares	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($) Plan $ / shares shares		Sep. 30, 2022 USD ($)	Sep. 15, 2023 USD ($) shares	Jun. 30, 2023 shares	Mar. 31, 2023 shares	Mar. 15, 2023 USD ($) shares	Jan. 01, 2023 shares	Oct. 31, 2022 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equity plans | Plan	4						4				4
Options granted (in shares)											0
Unrecognized compensation cost, recognition period	1 year 11 months 8 days
Options modified (in shares)						146,000
Options modified, expense | $											$ 1,366
Stock-based compensation expense | $							$ 997			$ 771	2,235		$ 3,159
Market-based awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost | $	$ 72						$ 72				$ 72
Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)						56,000												55,000
Common stock reserved for issuance remaining (in shares)	35,000						35,000				35,000
Common stock reserved for issuance, annual increase percentage																		2.50%
Common stock reserved for issuance, annual increase (in shares)																		56,000
2023 Awards | Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options, grants in period (in shares)				32,000
Vesting Period				4 months
2023 Awards | Restricted stock units | Non-employee Board members
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options, grants in period (in shares)			33,000
Vesting date			Aug. 20, 2023
2023 Awards | Restricted stock units | Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options, grants in period (in shares)			126,000
2023 Awards | Performance-based awards | Senior management
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options, grants in period (in shares)			24,000
2022 Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted (in shares)											5,000
Granted (in usd per share) | $ / shares											$ 39.6
2022 Awards | Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options, grants in period (in shares)											128,000
2022 Awards | Market-based awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost | $																			$ 34
Options granted, weighted average grant-date fair value (in usd per share) | $ / shares									$ 0.8
Market capitalization target | $									$ 1,000,000
2022 Awards | Performance-based awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options, grants in period (in shares)					7,000
Unrecognized compensation cost | $																			$ 7
Options granted, weighted average grant-date fair value (in usd per share) | $ / shares									$ 16.2
2021 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)						225,000
Common stock reserved for issuance, annual increase percentage																		10%
Common stock reserved for issuance, annual increase (in shares)																		225,000
Options outstanding (in shares)	5,000						5,000		5,000		5,000				5,000	5,000
2021 Plan | Stock option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted (in shares)											0
Common stock reserved for issuance (in shares)																		221,000
Common stock reserved for issuance remaining (in shares)	49,000						49,000				49,000
Total unrecognized compensation cost | $	$ 68						$ 68				$ 68
2021 Plan | Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost | $	$ 1,432						$ 1,432				$ 1,432
2021 Plan | Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, recognition period	2 years 7 months 9 days
2018 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding (in shares)	117,000	[1]					117,000	[1]	172,000		117,000	[1]			124,000	150,000
2018 Plan | Service-based awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost | $	$ 363						$ 363				$ 363
Unrecognized compensation cost, recognition period	1 year 7 months 17 days
Options outstanding (in shares)	64,000						64,000				64,000
2018 Plan | Market-based awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost | $	$ 585						$ 585				$ 585
Unrecognized compensation cost, recognition period	6 months 25 days
Options outstanding (in shares)	53,000						53,000				53,000
Market capitalization target | $						$ 1,000,000
Market capitalization target, threshold days | Days						20
Market capitalization target, threshold consecutive days						30 days
Earn-Out Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)									29,000
Earn-Out Plan | Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options, grants in period (in shares)											0
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares purchased														6,000			14,000
Total amount of shares purchased | $														$ 49			$ 120
Stock-based compensation expense | $							$ 11			$ 12	$ 78		$ 12
[1] Includes 64 and 53 awards accounted for as service-based and market-based options, respectively, that are vested, that the Company currently deems probable of vesting, or in the case of market-based options, that the Company is expensing so long as the respective service conditions are met. The market-based options will vest only if the price of the Company's common stock reaches a $ 1 billion market capitalization target for any 20 days during a 30 -day period on or before February 4, 2026.

Equity Incentive and Other Pl_4

Equity Incentive and Other Plans - Stock Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands							3 Months Ended
		Sep. 30, 2023		Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023		Jun. 30, 2023	Mar. 31, 2023
2021 Plan
Number of Shares
Outstanding (in shares)							5		5	5
Forfeited or expired (in shares)							0		0	0
Outstanding (in shares)		5		5			5		5	5
Vested and exercisable (in shares)		2					2
Weighted Average Exercise Price
Outstanding (in usd per share)							$ 39.56		$ 39.55	$ 39.52
Forfeited or expired (in usd per share)							16.26		38.31	32.08
Outstanding (in usd per share)		$ 39.58		$ 39.52			39.58		$ 39.56	$ 39.55
Vested and exercisable (in usd per share)		$ 39.56					$ 39.56
Aggregate Intrinsic Value
Outstanding		$ 0		$ 0			$ 0		$ 0	$ 0
Vested and exercisable		$ 0					$ 0
Weighted Average Remaining Contractual Term (in years)
Outstanding		8 years 10 months 17 days		9 years 7 months 9 days	9 years 1 month 20 days	9 years 4 months 17 days
Vested and exercisable		8 years 10 months 13 days
2018 Plan
Number of Shares
Outstanding (in shares)							124		150	172
Exercised (in shares)										0
Forfeited or expired (in shares)							(7)		(26)	(22)
Outstanding (in shares)		117	[1]	172			117	[1]	124	150
Vested and exercisable (in shares)		53					53
Weighted Average Exercise Price
Outstanding (in usd per share)							$ 34.17		$ 32.68	$ 32.06
Exercised (in usd per share)										8
Forfeited or expired (in usd per share)							31.57		25.5	27.97
Outstanding (in usd per share)		$ 34.29	[1]	$ 32.06			34.29	[1]	$ 34.17	$ 32.68
Vested and exercisable (in usd per share)		$ 26.91					$ 26.91
Aggregate Intrinsic Value
Outstanding	[1]	$ 8					$ 8
Vested and exercisable		$ 8					$ 8
Weighted Average Remaining Contractual Term (in years)
Outstanding	[1]	4 years 10 months 24 days
Vested and exercisable		5 years 11 months 23 days
[1] Includes 64 and 53 awards accounted for as service-based and market-based options, respectively, that are vested, that the Company currently deems probable of vesting, or in the case of market-based options, that the Company is expensing so long as the respective service conditions are met. The market-based options will vest only if the price of the Company's common stock reaches a $ 1 billion market capitalization target for any 20 days during a 30 -day period on or before February 4, 2026.

Equity Incentive and Other Pl_5

Equity Incentive and Other Plans - Restricted Stock Unit (Details) - 2021 Plan - Restricted Stock Units and Performance Stock Units - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2023
Number of Shares
Beginning balance (in shares)	50	93	103	103
Granted (in shares)	181		32
Vested (in shares)	(48)	(26)	(18)
Forfeited (in shares)	(1)	(17)	(24)
Ending balance (in shares)	182	50	93	182
Weighted Average Grant Date Fair Value
Beginning balance (in usd per share)	$ 20.69	$ 17.81	$ 25.92	$ 25.92
Granted (in usd per share)	6.2		9.65	$ 9.77
Vested (in usd per share)	7.52	11.88	18.79
Forfeited (in usd per share)	$ 9.18	18.61	20.07
Ending balance (in usd per share)		$ 20.69	$ 17.81
Granted, fair value	$ 1,128		$ 305
Vested, fair value	$ 323	$ 199	$ 188

Equity Incentive and Other Pl_6

Equity Incentive and Other Plans - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 997	$ 771	$ 2,235	$ 3,159
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	94	77	230	137
Product development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	141	86	347	123
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 762	$ 608	$ 1,658	$ 2,899

Equity Incentive and Other Pl_7

Equity Incentive and Other Plans - Summary of Defined Contribution Retirement (401k) Plan (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
401(k) matching contributions	$ 134	$ 225	$ 520	$ 684

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Thousands	Sep. 01, 2023	Dec. 31, 2022	Aug. 31, 2021	Jun. 30, 2021
Board Of Directors
Related Party Transaction [Line Items]
Administrative Fees Expense	$ 30
2021 Notes | Convertible Senior Notes
Related Party Transaction [Line Items]
Aggregate principal amount			$ 7,500	$ 23,970
Significant investor | 2021 Notes | Convertible Senior Notes
Related Party Transaction [Line Items]
Aggregate principal amount				$ 1,000
Related Party [Member] | Remaining in Accrued Expenses and Other Current Liabilities | Board Of Directors
Related Party Transaction [Line Items]
Other Liabilities		$ 10

Net (Loss) Income Per Share - N

Net (Loss) Income Per Share - Narrative (Details) - shares	Sep. 30, 2023	Sep. 30, 2022	Feb. 04, 2022
Sponsor, escrow shares
Schedule Of Reverse Recapitalization [Line Items]
Earn-out shares (in shares)	81,000	81,000	81,000

Net (Loss) Income Per Share - C

Net (Loss) Income Per Share - Computation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net (loss) income	$ (2,210)	$ (1,436)	$ (5,397)	$ 15,454	$ 14,759	$ (19,376)	$ (9,043)	$ 10,837
Income impact of FPAs	0			(3,939)			0	(346)
Income impact of convertible promissory notes	0			600			0	0
Total undistributed (loss) income	$ (2,210)			$ 12,115			$ (9,043)	$ 10,491
Weighted average shares outstanding (in shares)	2,011			1,779			1,974	1,763
Dilutive effect of FPAs (in shares)	0			177			0	57
Dilutive effect of convertible promissory notes	0			124			0	0
Dilutive effect of stock-based awards	0			69			0	104
Common stock and common stock equivalents (in shares)	2,011			2,149			1,974	1,924
Basic net (loss) income per share	$ (1.1)			$ 8.69			$ (4.58)	$ 6.15
Diluted net (loss) income per share	$ (1.1)			$ 5.64			$ (4.58)	$ 5.45

Net (Loss) Income Per Share - A

Net (Loss) Income Per Share - Antidilutive Shares (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	1,297	945	1,250	1,066
Shares subject to warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	523	523	523	523
Shares subject to convertible promissory notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	124	0	124	121
Shares subject to ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	13	14	11	14
Escrow Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	81	81	81	81
Shares subject to outstanding common stock options, RSUs and PSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	285	56	240	56
Shares subject to stockholder earn-out rights
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	271	271	271	271

Segment Reporting (Details)

Segment Reporting (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Segment Reporting Information [Line Items]
Revenue	$ 10,583	$ 11,781	$ 32,507	$ 35,251
Gross profit	9,420	10,266	28,760	30,840
Retail
Segment Reporting Information [Line Items]
Revenue	9,266	9,042	27,576	27,286
Gross profit	8,234	7,916	24,374	23,975
Brands
Segment Reporting Information [Line Items]
Revenue	1,317	2,739	4,931	7,965
Gross profit	$ 1,186	$ 2,350	$ 4,386	$ 6,865

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2023	Dec. 31, 2022	Aug. 01, 2022	Jun. 30, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (loss)		$ 14	$ 22,264	$ 295	$ 36,264
Derivative Liability, Statement of Financial Position [Extensible Enumeration]		Derivative liability		Derivative liability
Forward share purchase agreements derivative liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability								$ 13,824
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability		$ 143	997	$ 143	997	$ 157	$ 438		$ 37,084
Gain (loss)		14	22,264	295	36,264
Level 3 | Private warrants derivative liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability		113	662	113	662	121	182		3,693
Gain (loss)		8	3,031	69	3,254
Level 3 | Forward share purchase agreements derivative liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	[1]	0	0	0	0	0	0		17,763
Gain (loss)	[1]	0	3,940	0	346
Level 3 | Escrow shares derivative liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability		5	47	5	47	6	52		3,481
Gain (loss)		1	3,434	47	6,821
Level 3 | Stockholder earn-out rights derivative liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability		25	288	25	288	$ 30	$ 204		$ 12,147
Gain (loss)		$ 5	$ 11,859	$ 179	$ 25,843
[1] The forward share purchase agreements were settled effective August 1, 2022, at which time the fair value was $ 13,824 based on cash settlement.

Fair Value Measurements - Valua

Fair Value Measurements - Valuation Assumptions (Details)				9 Months Ended
	Jun. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)
Private warrants derivative liability | Exercise price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	230	230	230	230	230
Private warrants derivative liability | Stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	5.8	13	90	6.42	13.6
Private warrants derivative liability | Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.999	0.75	0.516	0.999	0.98
Private warrants derivative liability | Term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative, term	3 years 7 months 6 days	4 years 1 month 2 days	4 years 7 months 2 days	3 years 4 months 6 days	4 years 4 months 2 days
Private warrants derivative liability | Risk-free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.045	0.041	0.03	0.047	0.041
Private warrants derivative liability | Dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0	0	0	0	0
Forward share purchase agreements derivative liability | Exercise price one
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input			206.2
Forward share purchase agreements derivative liability | Exercise price three
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input			203.2
Forward share purchase agreements derivative liability | Stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input			90
Forward share purchase agreements derivative liability | Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input			0.704
Forward share purchase agreements derivative liability | Term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative, term			1 month 2 days
Forward share purchase agreements derivative liability | Risk-free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input			0.013
Forward share purchase agreements derivative liability | Dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input			0
Escrow shares derivative liability | First stock price trigger
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	270	270	270	270	270
Escrow shares derivative liability | Second stock price trigger
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	310	310	310	310	310
Escrow shares derivative liability | Stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	5.8	13	90	6.42	13.6
Escrow shares derivative liability | Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.986	0.86	0.68	0.986	0.79
Escrow shares derivative liability | Term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative, term	1 year 7 months 6 days	2 years 1 month 2 days	2 years 7 months 2 days	1 year 4 months 6 days	2 years 4 months 2 days
Escrow shares derivative liability | Risk-free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.051	0.044	0.03	0.054	0.042
Escrow shares derivative liability | Dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0	0	0	0	0
Stockholder earn-out rights derivative liability | First stock price trigger
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	270	270	270	270	270
Stockholder earn-out rights derivative liability | Second stock price trigger
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	310	310	310	310	310
Stockholder earn-out rights derivative liability | First revenue trigger
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	65,000,000	65,000,000	65,000,000	65,000,000	65,000,000
Stockholder earn-out rights derivative liability | Second revenue trigger
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	101,000,000	101,000,000	101,000,000	101,000,000	101,000,000
Stockholder earn-out rights derivative liability | Stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	5.8	13	90	6.42	13.6
Stockholder earn-out rights derivative liability | 2022 Revenue assumption
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	44,000,000	48,000,000	49,500,000	42,000,000	47,500,000
Stockholder earn-out rights derivative liability | Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.986	0.86	0.68	0.986	0.79
Stockholder earn-out rights derivative liability | Term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative, term	1 year 7 months 6 days	2 years 1 month 2 days	2 years 7 months 2 days	1 year 4 months 6 days	2 years 4 months 2 days
Stockholder earn-out rights derivative liability | Risk-free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.051	0.044	0.03	0.054	0.042
Stockholder earn-out rights derivative liability | Dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0	0	0	0	0